1
|
Iwata-Endo K, Sahashi K, Kawai K, Fujioka Y, Okada Y, Watanabe E, Iwade N, Ishibashi M, Mohammad M, Aldoghachi AF, Tuerde D, Fujiwara T, Hirai S, Okado H, Katsuno M, Watanabe H, Kanamitsu K, Neya M, Ishigaki S, Sobue G. Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes. MOLECULAR THERAPY. NUCLEIC ACIDS 2025; 36:102503. [PMID: 40206658 PMCID: PMC11979468 DOI: 10.1016/j.omtn.2025.102503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/23/2024] [Accepted: 02/28/2025] [Indexed: 04/11/2025]
Abstract
Tau, a microtubule-binding protein linked to tauopathies like Alzheimer's disease and frontotemporal lobar degeneration (FTLD), has 3-repeat (3R) and 4-repeat (4R) isoforms. Accumulation of the 4R-tau is associated with FTLD, progressive supranuclear palsy (PSP), and cortico-basal degeneration (CBD). We previously showed that a loss of fused in sarcoma (FUS) or splicing factor, proline- and glutamine-rich (SFPQ) promoted 4R-tau accumulation, which induced FTLD-like behaviors and neurodegeneration in mice. Here, we developed antisense oligonucleotides (ASOs) modified with 2'-O, 4'-C-ethylene-bridged nucleic acids (ENAs), reducing the 4R-tau/3R-tau ratio while maintaining total tau expression from the MAPT gene. In vitro screening identified EN-06 as the most effective ENA. Intracerebroventricular (ICV) administration of EN-06 corrected the 4R/3R-tau ratio in FUS-silenced humanized tau mice and human iPSC-derived neurons. This treatment ameliorated disease phenotypes, including aberrant behaviors, spine dysmorphology, and neurodegeneration. The half-life of EN-06 after a single ICV administration was approximately 6 months in the brain, with splicing correction effects that persisted for 2 years. The efficacy of EN-06 was higher than that of 2'-O-methoxyethyl (MOE)-modified ASO (MO-06). These findings highlight the potential of ENA-modified ASOs to reduce 4R-tau while preserving total MAPT expression, thus offering a safe and long-acting treatment for 4R-tau-associated tauopathies.
Collapse
Affiliation(s)
- Kuniyuki Iwata-Endo
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Kentaro Sahashi
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Kaori Kawai
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
- Institute for Glyco-core Research (iGCORE), Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
| | - Yusuke Fujioka
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Yohei Okada
- Department of Neural iPSC Research, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan
| | - Eri Watanabe
- Drug Discovery Initiative, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - Nobuyuki Iwade
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Minaka Ishibashi
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Moniruzzaman Mohammad
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
| | - Asraa Faris Aldoghachi
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
| | - Dilina Tuerde
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | | | - Shinobu Hirai
- Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8506, Japan
| | - Haruo Okado
- Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8506, Japan
| | - Masahisa Katsuno
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
- Institute for Glyco-core Research (iGCORE), Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
- Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Hirohisa Watanabe
- Department of Neurology, Fujita Health University, Toyoake, Aichi 470-1192, Japan
| | - Kayoko Kanamitsu
- Drug Discovery Initiative, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - Masahiro Neya
- KNC Laboratories Co., Ltd., Kobe, Hyogo 651-2271, Japan
| | - Shinsuke Ishigaki
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Gen Sobue
- Aichi Medical University, Nagakute, Aichi 480-1195, Japan
| |
Collapse
|
2
|
Takasaki A, Nishio Y, Satake Y, Kobayashi M, Sakai M, Mori K, Ishii K, Ikeda M. Primary Tauopathy With Logopenic/Semantic Mixed Progressive Aphasia and Frontotemporal Dementia-like Behavior. Cogn Behav Neurol 2025:00146965-990000000-00086. [PMID: 40249666 DOI: 10.1097/wnn.0000000000000391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2024] [Accepted: 02/24/2025] [Indexed: 04/20/2025]
Abstract
Here we present the cases of two individuals with language and behavioral symptoms indicative of the early clinical manifestations of both Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD). Phonological language symptoms similar to those evident in logopenic variant primary progressive aphasia suggested AD pathology, while semantic impairment and behavioral changes (ie, abnormal eating behavior and disinhibition) suggested a diagnosis of FTLD. Multimodal neuroimaging studies revealed underlying neuropathology indicative of primary tauopathy with presumable 3/4-repeat isoform, devoid of amyloid deposition. We suggest that these cases may represent a previously unrecognized syndrome associated with non-Alzheimer primary tauopathy.
Collapse
Affiliation(s)
- Akihiro Takasaki
- Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yoshiyuki Nishio
- Department of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development, Suita, Japan
| | - Yuto Satake
- Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan
| | - Matasaburo Kobayashi
- Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan
| | - Mariko Sakai
- Department of Rehabilitation, Yukoukai General Hospital, Ibaraki, Japan
| | - Kohji Mori
- Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan
| | - Kazunari Ishii
- Department of Radiology, Faculty of Medicine, Kindai University, Osakasayama, Japan
| | - Manabu Ikeda
- Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan
| |
Collapse
|
3
|
Ismeurt-Walmsley C, Giannoni P, Servant F, Mekki LN, Baranger K, Rivera S, Marin P, Lelouvier B, Claeysen S. The same but different: impact of animal facility sanitary status on a transgenic mouse model of Alzheimer's disease. mBio 2025:e0400124. [PMID: 40243365 DOI: 10.1128/mbio.04001-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2024] [Accepted: 03/25/2025] [Indexed: 04/18/2025] Open
Abstract
The gut-brain axis has emerged as a key player in the regulation of brain function and cognitive health. Gut microbiota dysbiosis has been observed in preclinical models of Alzheimer's disease and patients. Manipulating the composition of the gut microbiota enhances or delays neuropathology and cognitive deficits in mouse models. Accordingly, the health status of the animal facility may strongly influence these outcomes. In the present study, we longitudinally analyzed the fecal microbiota composition and amyloid pathology of 5XFAD mice housed in a specific opportunistic pathogen-free (SOPF) and a conventional facility. The composition of the microbiota of 5XFAD mice after aging in conventional facility showed marked differences compared to WT littermates that were not observed when the mice were bred in SOPF facility. The development of amyloid pathology was also enhanced by conventional housing. We then transplanted fecal microbiota (FMT) from both sources into wild-type (WT) mice and measured memory performance, assessed in the novel object recognition test, in transplanted animals. Mice transplanted with microbiota from conventionally bred 5XFAD mice showed impaired memory performance, whereas FMT from mice housed in SOPF facility did not induce memory deficits in transplanted mice. Finally, 18 weeks of housing SOPF-born animals in a conventional facility resulted in the reappearance of specific microbiota compositions in 5XFAD vs WT mice. In conclusion, these results show a strong impact of housing conditions on microbiota-associated phenotypes and question the relevance of breeding preclinical models in specific pathogen-free (SPF) facilities. IMPORTANCE Housing conditions affect the composition of the gut microbiota. Gut microbiota of 6-month-old conventionally bred Alzheimer's mice is dysbiotic. Gut dysbiosis is absent in Alzheimer's mice housed in highly sanitized facilities. Transfer of fecal microbiota from conventionally bred mice affects cognition. Microbiota of mice housed in highly sanitized facilities has no effect on cognition.
Collapse
Affiliation(s)
| | - Patrizia Giannoni
- IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France
| | | | - Linda-Nora Mekki
- IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France
| | - Kevin Baranger
- Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Santiago Rivera
- Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Philippe Marin
- IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France
| | | | - Sylvie Claeysen
- IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France
| |
Collapse
|
4
|
Morrow CB, Onyike C, Pantelyat A, Smith GS, Leoutsakos J, Faria AV, Graff-Radford NR, Darby RR, Ghoshal N, Staffaroni AM, Rascovsky K, Miyagawa T, Balaji A, Tsapkini K, Lapid MI, Mendez MF, Litvan I, Pascual B, Rojas JC, Wszolek ZK, Domoto-Reilly K, Kornak J, Kamath V. Hyperorality in Frontotemporal Dementia: How Psychiatric and Neural Correlates Change During the Disease Course. J Neuropsychiatry Clin Neurosci 2025:appineuropsych20240134. [PMID: 40134270 DOI: 10.1176/appi.neuropsych.20240134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/27/2025]
Abstract
OBJECTIVE Hyperorality is a core feature of behavioral variant frontotemporal dementia (bvFTD); however, the cognitive, psychiatric, and neuroanatomical correlates of hyperorality across the bvFTD stages remain unclear. The authors explored these associations in early- and advanced-stage bvFTD. METHODS Participants with sporadic or genetic bvFTD were enrolled in the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) consortium study. Baseline cognitive and psychiatric symptoms of participants with or without hyperorality were compared after stratification by disease severity. Linear multivariable regressions adjusted for age and total intracranial volume were used to examine associations between regional gray matter volume (GMV) and hyperorality status. Five anatomical regions of interest were preselected for analysis on the basis of previously identified neuroanatomical correlates of hyperorality in bvFTD. RESULTS Hyperorality was present in 50% of early-stage bvFTD participants (N=136) and was associated with higher rates of ritualistic-compulsive behavior and difficulty detecting social-emotional expressions. Hyperorality was present in 63% of advanced-stage participants (N=208) and was associated with higher rates of apathy, ritualistic-compulsive behavior, and socially aberrant behavior. Regional GMV was similar for those with or without hyperorality among early-stage participants. Among advanced-stage participants, hyperorality was associated with lower GMV in the right dorsal and ventral striatum. CONCLUSIONS Hyperorality emerged early in bvFTD and was accompanied by deficits in social cognition and complex-ritualistic behavior before clinically significant GMV loss. These findings suggest that early identification and management of hyperorality could improve neuropsychiatric trajectories in bvFTD.
Collapse
Affiliation(s)
- Christopher B Morrow
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Chiadi Onyike
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Alexander Pantelyat
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Gwenn S Smith
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Jeannie Leoutsakos
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Andreia V Faria
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Neill R Graff-Radford
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - R Ryan Darby
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Nupur Ghoshal
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Adam M Staffaroni
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Katya Rascovsky
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Toji Miyagawa
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Akshata Balaji
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Kyrana Tsapkini
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Maria I Lapid
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Mario F Mendez
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Irene Litvan
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Belen Pascual
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Julio C Rojas
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Zbigniew K Wszolek
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Kimiko Domoto-Reilly
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - John Kornak
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| | - Vidyulata Kamath
- Department of Psychiatry and Behavioral Sciences (Morrow, Onyike, Smith, Leoutsakos, Balaji, Kamath), Department of Neurology (Pantelyat, Tsapkini), and Russell Morgan Department of Radiology (Smith, Faria), Johns Hopkins University School of Medicine, Baltimore; Department of Neurology, Mayo Clinic, Jacksonville, Fla. (Graff-Radford, Wszolek); Department of Neurology, Vanderbilt University Medical Center, Nashville (Darby); Department of Neurology, Washington University School of Medicine, St. Louis (Ghoshal); Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences (Staffaroni, Rojas), and Department of Epidemiology and Biostatistics (Kornak), University of California San Francisco, San Francisco; Department of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia (Rascovsky); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minn. (Miyagawa, Lapid); Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles (Mendez); Department of Neurosciences, University of California San Diego, La Jolla (Litvan); Department of Neurology, Houston Methodist Research Institute, Houston (Pascual); Department of Neurology, University of Washington School of Medicine, Seattle (Domoto-Reilly)
| |
Collapse
|
5
|
Gibbs HD, Taylor MK, Gibson C, Mount RR, Sullivan A, Williams K, Sullivan DK. Uncovering nutrition needs in dyads of caregivers and persons with dementia. J Alzheimers Dis 2025; 104:525-536. [PMID: 39956970 DOI: 10.1177/13872877251317737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2025]
Abstract
BackgroundNutrition risk is common in Alzheimer's disease and is associated with symptoms of dementia, cognitive decline, institutionalization, and mortality. Family caregivers who increasingly manage nutrition needs of persons with dementia (PWD) experience high caregiver burden, low health literacy, and nutrition risk. Few interventions for informal caregivers have included nutrition.ObjectiveTo inform design of a future caregiver nutrition intervention.MethodsThis cross-sectional study used a convergent mixed methods approach to 1) assess nutrition status among PWD and caregiver dyads (measures in common included Mini Nutrition Assessment, skin carotenoid, and handgrip strength), and 2) interview caregivers to identify needs and barriers for nutrition intervention. We hypothesized caregiver nutrition literacy is associated with PWD nutrition risk. Data collected in nutrition assessment and interviews were analyzed separately then side-by-side for comparison.ResultsOf 50 dyads, 48% had at least one individual exhibiting nutrition risk, and nutrition status categories (χ2 = 6.25, p = 0.012) between caregivers and PWD were related. Caregiver nutrition literacy was associated with 1) PWD factors including nutrition risk (rho = 0.244), body mass index (BMI) (rho = 0.421), handgrip strength (rho = 0.283), and skin carotenoid (rho = 0.351), and 2) Caregiver factors including nutrition risk (rho = 0.304), diet quality (rho = 0.304), and BMI (rho = 0.333). Interviews with 18 caregivers found caregivers prioritize PWD nutrition, provide more PWD nutrition care since diagnosis, experience social isolation, and would attend nutrition interventions if PWD are included.ConclusionsNutrition risk was more common among caregivers when PWD demonstrated nutrition risk. Factors present in individuals within the dyad were associated with partner nutrition risk. Future research should identify effective approaches for intervening on dyadic nutrition risk.
Collapse
Affiliation(s)
- Heather D Gibbs
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA
| | - Matthew K Taylor
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA
| | - Cheryl Gibson
- Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA
| | - Rebecca R Mount
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA
| | - Austin Sullivan
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA
| | - Kristine Williams
- School of Nursing, University of Kansas Medical Center, Kansas City, KS, USA
| | - Debra K Sullivan
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA
| |
Collapse
|
6
|
Liang S, Xi SZ, Liu JY, Tang GC, Zhang WG, Guo XR, Yang C, Zhang C, Cai GY. Global burden and cross-country inequalities of nutritional deficiencies in adults aged 65 years and older, 1990-2021: population-based study using the GBD 2021. BMC Geriatr 2025; 25:74. [PMID: 39893435 PMCID: PMC11786432 DOI: 10.1186/s12877-025-05728-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2024] [Accepted: 01/22/2025] [Indexed: 02/04/2025] Open
Abstract
BACKGROUND/OBJECTIVES Nutritional deficiencies remain significant public health issues in older populations globally. This study evaluates the burden, trends, and cross-country inequalities of four common nutritional deficiencies (protein-energy malnutrition, iodine deficiency, vitamin A deficiency, and dietary iron deficiency) in older adults from 1990 to 2021. METHODS Age-standardised prevalence, disability-adjusted life years (DALYs), and average annual percentage changes (AAPCs) of these deficiencies in people aged ≥ 65 years at global, regional, and national levels were estimated from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. Cross-country inequalities in disease burden were quantified using the slope index and concentration index, standard health equity methods recommended by the World Health Organization. RESULTS Globally, age-standardised prevalence rates of protein-energy malnutrition increased from 1407.16 per 100 000 population in 1990 to 2015.58 in 2021, with an AAPC of 1.18 (1.08-1.28), showing significant changes in 2015 and 2019, which were turning points in the joinpoint regression. Age-standardised prevalence rates of iodine, vitamin A, and dietary iron deficiencies decreased, with AAPCs of -0.49 (-0.53 to -0.44), -3.24 (-3.27 to -3.20), and - 0.14 (-0.17 to -0.12), respectively. Except for an increase in the DALY rate of vitamin A deficiency (AAPC 0.40), the DALY rates of the other three deficiencies decreased. Inequality in the burden of protein-energy malnutrition and iodine deficiency between high- and low-income countries narrowed, while inequality for vitamin A and dietary iron deficiencies remained stable. Age-standardised DALY rates for all deficiencies decreased as sociodemographic index increased. CONCLUSIONS The global status of nutritional deficiency among older adults has improved since 1990, but the increasing prevalence of protein-energy malnutrition requires attention. Additionally, cross-country health inequalities persist, necessitating more efficient public health measures.
Collapse
Affiliation(s)
- Shuang Liang
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Shao-Zhi Xi
- Department of General Internal Medicine, The Second Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Jia-Yi Liu
- Department of Rehabilitation Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China
| | - Gui-Chun Tang
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Wei-Guang Zhang
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Xin-Ru Guo
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Chen Yang
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Chun Zhang
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China
| | - Guang-Yan Cai
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China.
| |
Collapse
|
7
|
Kato K, Lopes KDS, Matsumoto-Takahashi ELA. Risk Factors Associated with Oral Intake Discontinuation in Hospitalized Patients with Aspiration Pneumonia: A Scoping Review. JMA J 2025; 8:11-17. [PMID: 39926060 PMCID: PMC11799607 DOI: 10.31662/jmaj.2024-0077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Accepted: 10/21/2024] [Indexed: 02/11/2025] Open
Abstract
Background Aspiration pneumonia is a prevalent condition, and understanding the risk factors associated with discontinuation of oral intake upon discharge is crucial. This study aimed to identify such factors, thereby providing valuable insights for optimizing the use of limited healthcare resources and enhancing patient and family care. Methods In this scoping review, data were collected through ICHUSHI using the search formula "Pneumonia-Aspiration/Thesaurus or Aspiration Pneumonia/All) and (Prognosis/Thesaurus or Prognosis/All)." The inclusion criteria encompassed Japanese patients hospitalized for aspiration pneumonia, with a clear outcome focused on the availability of oral intake. The exclusion criteria included text unavailability, studies from foreign countries, and cases involving not hospitalized patients. The risk of bias for each study was assessed using the Newcastle-Ottawa scale. Results Using this search formula, 1,646 articles were initially identified, culminating in the inclusion of six articles for analysis. The investigation revealed five significant risk factors: social status (age and gender), nutritional status (body mass index, Controlling Nutritional Status score, serum albumin, Basal Energy Expenditure, and low body weight), physical swallowing function (ambulatory ability before admission, Food Intake LEVEL scale (FILS), admission origin, bedridden status, Penetration-Aspiration scale, presence of residual pharyngeal material, and Basal Index), pneumonia severity (A-DROP score, a classification tool incorporating age, dehydration, oxygen demand, impaired consciousness, and hypotension), and comorbidities (pneumonia, dementia, mental illness, malignancy, chronic lower respiratory tract involvement, and renal failure). Conclusions This scoping review identified five key risk factors associated with oral intake discontinuation upon discharge in patients hospitalized for aspiration pneumonia, providing valuable evidence for future clinical practice.
Collapse
Affiliation(s)
- Kokoro Kato
- Graduate School of Public Health, St. Luke's International University, Tokyo, Japan
- Fujita Health University, Okazaki Medical Center, Aichi, Japan
| | - Katharina da Silva Lopes
- Institute of Child Nutrition, Federal Research Institute of Nutrition and Food, Karlsruhe, Germany
| | | |
Collapse
|
8
|
Yamashita R, Beck G, Shigenobu K, Tarutani A, Yonenobu Y, Kawai M, Mori K, Tahara S, Satake Y, Saito Y, Morii E, Hasegawa M, Ikeda M, Mochizuki H, Murayama S. Motor involvement in frontotemporal lobar degeneration with TAR DNA-binding protein of 43 kDa type C. Neuropathology 2025. [PMID: 39809580 DOI: 10.1111/neup.13026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 12/15/2024] [Accepted: 12/17/2024] [Indexed: 01/16/2025]
Abstract
The degeneration of pyramidal tracts has been reported in frontotemporal lobar degeneration with TDP-43 (TAR DNA-binding protein 43) pathology (FTLD-TDP) type C. Herein, we examined the detailed pathology of the primary motor area and pyramidal tracts in the central nervous system in four autopsy cases of FTLD-TDP type C, all of which were diagnosed by neuropathological, biochemical, and genomic analyses. Three patients showed right dominant atrophy of the frontal and temporal lobes, while the other patient showed left dominant atrophy. All four patients showed motor symptoms, and two patients had episodes of repeated aspiration. In the primary motor area, phosphorylated TDP-43 (p-TDP-43) or annexin A11-immunoreactive long dystrophic neurites were observed in all cases, and neuronophagia of the Betz cells was frequently observed in two of four cases. In the lower motor system, p-TDP-43 or annexin A11-positive dystrophic neurites were detected in the anterior horn of the spinal cord. Immuno-electron microscopy of the insoluble fraction extracted from all cases showed p-TDP-43 or annexin A11-labelled filaments. In FTLD-TDP type C, neurodegeneration with TDP and annexin A11 pathology was observed mainly in the upper motor neurons of both patients with right- and left predominant temporal atrophy and a short disease duration. Furthermore, a combination of TDP-43 and annexin A11 pathology was visible in the lower motor neurons, albeit less frequently. In summary, we reported the TDP-43 and annexin A11-associated involvement of anterior horn cells of the spinal cord for the first time. The degeneration of the motor system could contribute to dysphagia and aspiration pneumonia at the late stage of FTLD-TDP type C. Little or no TDP pathology was found in the corticospinal tract, unlike in FTLD-TDP type B, suggesting the occurrence of secondary degeneration in FTLD-TDP type C.
Collapse
Affiliation(s)
- Rika Yamashita
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Goichi Beck
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Kazue Shigenobu
- Asakayama General Hospital, Osaka, Japan
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Airi Tarutani
- Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Yuki Yonenobu
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Makiko Kawai
- Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Kohji Mori
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Shinichiro Tahara
- Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Yuto Satake
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Yuko Saito
- Brain Bank for Aging Research (Neuropathology), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan
| | - Eiichi Morii
- Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Masato Hasegawa
- Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Manabu Ikeda
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Hideki Mochizuki
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Shigeo Murayama
- Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
- Brain Bank for Aging Research (Neuropathology), Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan
- Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan
| |
Collapse
|
9
|
Tang H, Zhang W, Shen H, Yan P, Li L, Liu W, Xu C, Zhao H, Shang L. Development and preliminary validation of the Dietary Self-management Behavior Questionnaire (DSMBQ) for breast cancer patients during chemotherapy: three rounds of survey. BMC Public Health 2024; 24:3579. [PMID: 39719570 DOI: 10.1186/s12889-024-21128-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Accepted: 12/17/2024] [Indexed: 12/26/2024] Open
Abstract
BACKGROUND Adverse effects during chemotherapy severely impact the daily diet of breast cancer (BC) patients. Engaging in dietary self-management is crucial for healthy lifestyle and recovery. This study aims to create the Dietary Self-management Behavior Questionnaire (DSMBQ) and preliminarily validate its reliability, validity, and discriminative ability for BC patients undergoing chemotherapy. METHODS The questionnaire was developed through a scoping review, patient interviews, and referenced to previous scales. The initial draft item pool underwent two rounds of Delphi expert consultations, creating the draft DSMBQ with 6 predefined dimensions and 98 items. Subsequently, the draft questionnaire underwent three rounds of investigation. The results from the first two surveys were utilized for item selection, the third was to assess the construct of the final DSMBQ. Three groups (n = 158, 385, and 771) were conveniently sampled from three hospitals in Xi'an and Zhengzhou cities. Lastly, 150, 378, and 760 participants, respectively, completed valid questionnaires. Exploratory factor analysis and variability analysis were used to assess the draft questionnaire, and the structure was further examined through confirmatory factor analysis. RESULTS The final DSMBQ comprised 22 items organized into 4 dimensions. The cumulative variance contribution rate totaled 62.96%. The Cronbach's α demonstrated high internal consistency at 0.91, while the split-half reliability coefficient was 0.83, and the test-retest reliability coefficient reached 0.94. Correlation coefficients between the scores of each dimension and the total score ranged from 0.697 to 0.751. With the exception of the normed fit index (NFI) and the non-normed fit index (NNFI) at 0.89 (close to 0.90), all other indicators met statistical requirements. Patients exhibited varying average scores for each dimension of the DSMBQ based on differences in age, education level, Body Mass Index (BMI), menopausal status, and cancer stage (P < 0.05). CONCLUSION The DSMBQ demonstrated good reliability, validation, and discriminative ability in Chinese BC patients undergoing chemotherapy. Tailored to the cultural context, the DSMBQ emerges as a high-quality tool for the nuanced assessment of dietary self-management in BC patients by focusing on lifestyle behavior changes. It holds the potential to enhance subjective initiative and confidence, facilitating increased patient participation in their healthcare.
Collapse
Affiliation(s)
- Han Tang
- Department of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, 710032, China
- School of Nursing, Wenzhou Medical University, Wenzhou, 325035, China
| | - Wei Zhang
- Department of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, 710032, China
| | - Haiyan Shen
- Department of Orthopedics 1, Sichuan Provincial People's Hospital, Chengdu, 610072, China
| | - Pei Yan
- Department of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, 710032, China
- Department of Operation Room, The First Affiliated Hospital, Air Force Medical University, Xi'an, 710032, China
| | - Liang Li
- Department of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, 710032, China
| | - Wei Liu
- Department of Breast Surgery 2 (Area 1), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China
| | - Chao Xu
- Department of Knee Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
| | - Huadong Zhao
- Department of General Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, 710038, China.
| | - Lei Shang
- Department of Health Statistics, School of Public Health, The Fourth Military Medical University, Xi'an, 710032, China.
| |
Collapse
|
10
|
Clain AE, Samia N, Davidson K, Martin-Harris B. Characterizing Physiologic Swallowing Impairment Profiles: A Large-Scale Exploratory Study of Head and Neck Cancer, Stroke, Chronic Obstructive Pulmonary Disease, Dementia, and Parkinson's Disease. JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH : JSLHR 2024; 67:4689-4713. [PMID: 39556042 DOI: 10.1044/2024_jslhr-24-00091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2024]
Abstract
PURPOSE The purpose of the present study was to use a large swallowing database to explore and compare the swallow-physiology impairment profiles of five dysphagia-associated diagnoses: chronic obstructive pulmonary disease (COPD), dementia, head and neck cancer (HNC), Parkinson's disease (PD), and stroke. METHOD A total of 8,190 patients across five diagnoses were extracted from a de-identified swallowing database, that is, the Modified Barium Swallow Impairment Profile Swallowing Data Registry, for the present exploratory cross-sectional analysis. To identify the impairment profiles of the five diagnoses, we fit 18 partial proportional odds models, one for each of the 17 Modified Barium Swallow Impairment Profile components and the Penetration-Aspiration Scale, with impairment score as the dependent variable and diagnoses, age, sex, and race as the independent variables with interactions between age and diagnoses and between PD and dementia (in effect creating a PD with dementia [PDwDem] group). For components with > 5% missingness, we applied inverse probability weighting to correct for bias. RESULTS PD and COPD did not significantly differ on 13 of the 18 outcome variables (all ps > .02). Dementia, stroke, and PDwDem all showed worse impairments than COPD or PD on five of six oral components (all ps < .007). HNC had worse impairment than all diagnoses except PDwDem for nine of 10 pharyngeal components (all ps < .006). Stroke and HNC had worse penetration/aspiration than all other diagnoses (all ps < .003). CONCLUSIONS The present results show that there are both common and differing impairment profiles among these five diagnoses. These commonalities and differences in profiles provide a basis for the generation of hypotheses about the nature and severity of dysphagia in these populations. These results are also likely highly generalizable given the size and representativeness of the data set. SUPPLEMENTAL MATERIAL https://doi.org/10.23641/asha.27478245.
Collapse
Affiliation(s)
- Alex E Clain
- Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL
| | - Noelle Samia
- Department of Statistics and Data Science, Northwestern University, Evanston, IL
| | - Kate Davidson
- Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston
| | - Bonnie Martin-Harris
- Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL
- Edward Hines, Jr. VA Hospital, Hines, IL
| |
Collapse
|
11
|
Zhang NK, Zhang SK, Zhang LI, Tao HW, Zhang GW. The neural basis of neuropsychiatric symptoms in Alzheimer's disease. Front Aging Neurosci 2024; 16:1487875. [PMID: 39703925 PMCID: PMC11655510 DOI: 10.3389/fnagi.2024.1487875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Accepted: 11/19/2024] [Indexed: 12/21/2024] Open
Abstract
Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy and aggression affect up to 90% of Alzheimer's disease (AD) patients. These symptoms significantly increase caregiver stress and institutionalization rates, and more importantly they are correlated with faster cognitive decline. However, the neuronal basis of NPS in AD remains largely unknown. Here, we review current understanding of NPS and related pathology in studies of AD patients and AD mouse models. Clinical studies indicate that NPS prevalence and severity vary across different AD stages and types. Neuroimaging and postmortem studies have suggested that pathological changes in the anterior cingulate cortex, hippocampus, prefrontal cortex, and amygdala are linked to NPS, although the precise mechanisms remain unclear. Studies of AD mouse models have indicated that amyloid-beta and tau-related neurodegeneration in the hippocampus, prefrontal cortex, and anterior cingulate cortex are correlated with NPS-like behavioral deficits. A better understanding of the NPS phenotypes and related pathological changes will pave the way for developing a better management strategy for NPS in AD patients.
Collapse
Affiliation(s)
- Nicole K. Zhang
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
| | - Selena K. Zhang
- Biomedical Engineering Program, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States
| | - Li I. Zhang
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
- Department of Physiology and Neuroscience, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
| | - Huizhong W. Tao
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
- Department of Physiology and Neuroscience, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
| | - Guang-Wei Zhang
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
- Department of Physiology and Neuroscience, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
| |
Collapse
|
12
|
Altomare D, Bracca V, Premi E, Micheli A, Cotelli MS, Gasparotti R, Alberici A, Borroni B. Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration. Psychiatry Clin Neurosci 2024; 78:818-825. [PMID: 39375835 PMCID: PMC11612539 DOI: 10.1111/pcn.13751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 09/04/2024] [Accepted: 09/11/2024] [Indexed: 10/09/2024]
Abstract
AIM Empirical research investigating hyperorality in syndromes associated with frontotemporal lobar degeneration (FTLD) is limited. The present study aims to assess and describe hyperorality and its clinical and imaging correlates in patients with FTLD-associated syndromes. METHODS This retrospective longitudinal study included consecutive patients with FTLD who underwent a clinical, cognitive, and behavioral assessment. The presence and severity of hyperorality was assessed using the Frontal Behavior Inventory. RESULTS A total of 712 patients with FTLD were included in the study. Hyperorality was reported by 29% (204 of 712 [95% CI: 25-32%]) of patients; was more frequent in those with severe dementia than in those with prodromal or mild to moderate dementia (P < 0.05); was associated with younger age (odds ratio [OR] = 0.96 [95% CI: 0.94-0.99]), (P = 0.003) and positive family history for dementia (OR = 2.03 [95% CI: 1.18-3.49], P = 0.010); was overall more probable in the behavioral variant of frontotemporal dementia (bvFTD) and frontotemporal dementia with amyotrophic lateral sclerosis phenotypes, and less probable in other language or motor phenotypes; and was associated with higher severity of neuropsychiatric symptoms (OR = 1.08 [95% CI: 1.06-1.10], P < 0.001) and with the presence of several behavioral symptoms (P < 0.05). Moreover, hyperorality severity increased over time only in patients with bvFTD (β = +0.15, P = 0.011) or semantic variant of primary progressive aphasia (β = +0.34, P = 0.010). Finally, the presence of hyperorality was significantly associated with greater atrophy in the right anterior insula and right orbitofrontal region (false discovery rate-corrected P < 0.05). CONCLUSION Hyperorality is common in certain FTLD-associated syndromes. Understanding its correlates can help clinicians define pharmacological and educational interventions and clarify related anatomical circuits.
Collapse
Affiliation(s)
- Daniele Altomare
- Department of Clinical and Experimental SciencesUniversity of BresciaBresciaItaly
| | - Valeria Bracca
- Department of Molecular and Translational MedicineUniversity of BresciaBresciaItaly
| | - Enrico Premi
- Stroke UnitAzienda Socio Sanitaria Territoriale (ASST) Spedali CiviliBresciaItaly
| | - Anna Micheli
- Casa di Cura San FrancescoIstituto Madre RubattoBergamoItaly
| | - Maria Sofia Cotelli
- Department of Continuity of Care and FrailtyAzienda Socio Sanitaria Territoriale (ASST) Spedali CiviliBresciaItaly
| | | | - Antonella Alberici
- Department of Continuity of Care and FrailtyAzienda Socio Sanitaria Territoriale (ASST) Spedali CiviliBresciaItaly
| | - Barbara Borroni
- Department of Clinical and Experimental SciencesUniversity of BresciaBresciaItaly
- Department of Continuity of Care and FrailtyAzienda Socio Sanitaria Territoriale (ASST) Spedali CiviliBresciaItaly
| |
Collapse
|
13
|
Chan CTW, Wu TY, Cheng I. A systematic review on dysphagia treatments for persons living with dementia. Eur Geriatr Med 2024; 15:1573-1585. [PMID: 39612080 PMCID: PMC11632040 DOI: 10.1007/s41999-024-01107-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Accepted: 11/06/2024] [Indexed: 11/30/2024]
Abstract
PURPOSE Dysphagia in persons living with dementia (PLWD) is raising concern due to the absence of swallowing treatments specific to this population. Dysphagia can result in detrimental effects, such as malnutrition, dehydration, and aspiration pneumonia. This systematic review aimed to evaluate the existing literature on dysphagia management of PLWD and reveal their limitations to facilitate clinical practitioners in decision-making. METHODS Five electronic databases were searched systematically from the date of inception to January 2024 by two independent reviewers. Eligible studies investigated any treatments with outcome measurements evaluating swallowing function. Qualitative analyses were performed. RESULTS A total of 10 studies, involving 1360 participants, were included in the systematic review. They were analyzed qualitatively and evaluated for quality. Studies included were observational (n = 5) with prospective or retrospective designs, and randomized controlled trials (n = 5). Compensatory, rehabilitative, stimulation, and pharmacological treatments were addressed. CONCLUSION There is currently limited evidence available revealing the efficacy of dysphagia treatments for PLWD. Based on the current evidence, no definitive conclusions can be drawn on which treatments are more effective for this population. In the future, more randomized controlled trials with large sample sizes investigating the long-term effects of treatments are warranted.
Collapse
Affiliation(s)
- Charis Tsz Wun Chan
- Academic Unit of Human Communication, Learning and Development, Faculty of Education, The University of Hong Kong, Room 766, 7/F, Meng Wah Complex, Hong Kong, China
| | - Tsz Yin Wu
- Academic Unit of Human Communication, Learning and Development, Faculty of Education, The University of Hong Kong, Room 766, 7/F, Meng Wah Complex, Hong Kong, China
| | - Ivy Cheng
- Academic Unit of Human Communication, Learning and Development, Faculty of Education, The University of Hong Kong, Room 766, 7/F, Meng Wah Complex, Hong Kong, China.
- Centre for Gastrointestinal Sciences, Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
| |
Collapse
|
14
|
Saucedo-Figueredo MC, Morilla-Herrera JC, Gálvez-González M, Rivas-Ruiz F, Nava-DelVal A, San Alberto-Giraldos M, Hierrezuelo-Martín MJ, Gómez-Borrego AB, Kaknani-Uttumchandani S, Morales-Asencio JM. Anchor-Based and Distributional Responsiveness of the Spanish Version of the Edinburgh Feeding Evaluation in Dementia Scale in Older People with Dementia: A Longitudinal Study. Nutrients 2024; 16:3863. [PMID: 39599649 PMCID: PMC11597151 DOI: 10.3390/nu16223863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2024] [Revised: 11/06/2024] [Accepted: 11/08/2024] [Indexed: 11/29/2024] Open
Abstract
BACKGROUND/OBJECTIVES Patients with dementia present with feeding difficulties (FDs) since diagnosis, conditioning their progression. Early identification is vital for preventing deterioration due to nutritional problems. The Edinburgh Feeding Evaluation in Dementia Scale (EdFED) identifies the FDs of patients with dementia by studying their behaviours while eating or being fed. The aim of this study was to assess the responsiveness of the EdFED over time in older people with cognitive impairment and to compare its effectiveness in identifying malnutrition and risk with that of the gold standard Mini Nutritional Assessment (MNA) method. METHODS This was a multicentre, prospective, observational, longitudinal, analytic study with a follow-up period of 18 months (with patients participating in nursing homes and in the community). Sociodemographic and nutritional data (body mass index (BMI), MNA, forearm circumference (FC), calf circumference (CC), and a nutritional blood test) were collected; EdFED score was reported by nurses, nursing assistants, and family caregivers. RESULTS The total sample consisted of 359 individuals-60.7% residential participants and 39.3% community participants. In the last follow-up there were 149 remaining (41.5%). Malnutrition was more than 30%, and the risk was 40% at the three follow-ups. The results suggest that the EdFED scale is a useful tool for assessing feeding difficulties (FDs) in older persons with dementia. It demonstrated good sensitivity and specificity in detecting malnutrition, similar to the MNA, and, more importantly, detecting risk and also identifying changes in nutritional status over time. CONCLUSIONS The EdFED scale provides a means of evaluating nutritional problems, making it possible to work on prevention.
Collapse
Affiliation(s)
- Maria Carmen Saucedo-Figueredo
- IR Group C-13 “Chronicity, Dependency, Health Care and Services”, Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA BIONAND Platform), 29071 Malaga, Spain; (S.K.-U.); (J.M.M.-A.)
- Clinical Management Unit Los Boliches, Andalusian Health Service, District Costa del Sol, 29603 Malaga, Spain;
| | - Juan Carlos Morilla-Herrera
- Clinical Management Unit Los Boliches, Andalusian Health Service, District Costa del Sol, 29603 Malaga, Spain;
- Nursing Home, Unit Málaga-Gualdalhorce, Andalusian Health Service, District Málaga, 29603 Malaga, Spain
| | - María Gálvez-González
- Clinical Management Unit La Carihuela, Andalusian Health Service, District Costa del Sol, 29603 Malaga, Spain;
| | - Francisco Rivas-Ruiz
- Secretary Costa del Sol Research & Ethics Committee, Costa del Sol University Hospital, 29603 Malaga, Spain;
| | - Antonia Nava-DelVal
- Clinical Management Unit Las Albarizas, Andalusian Health Service District Costa del Sol, 29603 Malaga, Spain;
| | | | | | - Ana Belén Gómez-Borrego
- Estepona Community, Mental Health Unit, Virgen de la Victoria University Hospital, 29010 Malaga, Spain;
| | - Shakira Kaknani-Uttumchandani
- IR Group C-13 “Chronicity, Dependency, Health Care and Services”, Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA BIONAND Platform), 29071 Malaga, Spain; (S.K.-U.); (J.M.M.-A.)
- Faculty of Health Sciences, University of Málaga, 29071 Malaga, Spain
| | - José Miguel Morales-Asencio
- IR Group C-13 “Chronicity, Dependency, Health Care and Services”, Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA BIONAND Platform), 29071 Malaga, Spain; (S.K.-U.); (J.M.M.-A.)
- Faculty of Health Sciences, University of Málaga, 29071 Malaga, Spain
| |
Collapse
|
15
|
Meng L, Jin H, Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Shoaie S, Turkez H, Nielsen J, Zhang C, Borén J, Uhlén M, Mardinoglu A. Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease. Alzheimers Res Ther 2024; 16:213. [PMID: 39358810 PMCID: PMC11448018 DOI: 10.1186/s13195-024-01578-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Accepted: 09/22/2024] [Indexed: 10/04/2024]
Abstract
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder with a global impact, yet its pathogenesis remains poorly understood. While age, metabolic abnormalities, and accumulation of neurotoxic substances are potential risk factors for AD, their effects are confounded by other factors. To address this challenge, we first utilized multi-omics data from 87 well phenotyped AD patients and generated plasma proteomics and metabolomics data, as well as gut and saliva metagenomics data to investigate the molecular-level alterations accounting the host-microbiome interactions. Second, we analyzed individual omics data and identified the key parameters involved in the severity of the dementia in AD patients. Next, we employed Artificial Intelligence (AI) based models to predict AD severity based on the significantly altered features identified in each omics analysis. Based on our integrative analysis, we found the clinical relevance of plasma proteins, including SKAP1 and NEFL, plasma metabolites including homovanillate and glutamate, and Paraprevotella clara in gut microbiome in predicting the AD severity. Finally, we validated the predictive power of our AI based models by generating additional multi-omics data from the same group of AD patients by following up for 3 months. Hence, we observed that these results may have important implications for the development of potential diagnostic and therapeutic approaches for AD patients.
Collapse
Affiliation(s)
- Lingqi Meng
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
| | - Han Jin
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
| | - Burak Yulug
- Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey
| | - Ozlem Altay
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
| | - Xiangyu Li
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
| | - Lutfu Hanoglu
- Department of Neurology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey
| | - Seyda Cankaya
- Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey
| | - Ebru Coskun
- Department of Neurology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey
| | - Ezgi Idil
- Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey
| | - Rahim Nogaylar
- Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey
| | - Ahmet Ozsimsek
- Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey
| | - Saeed Shoaie
- Centre for Host-Microbiome Interaction's, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK
| | - Hasan Turkez
- Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Cheng Zhang
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
| | - Jan Borén
- Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Mathias Uhlén
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
| | - Adil Mardinoglu
- Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
- Centre for Host-Microbiome Interaction's, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.
| |
Collapse
|
16
|
Bathini P, Brai E, Balin BJ, Bimler L, Corry DB, Devanand DP, Doty RL, Ehrlich GD, Eimer WA, Fulop T, Hahn DL, Hammond CJ, Infanti J, Itzhaki R, Lathe R, Little CS, McLeod R, Moein ST, Nelson AR, Perry G, Shemesh OA, Tanzi RE, Webley WC, Schultek NM, Alberi Auber L. Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease. J Infect Dis 2024; 230:S150-S164. [PMID: 39255393 DOI: 10.1093/infdis/jiae328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/12/2024] Open
Abstract
Sensory functions of organs of the head and neck allow humans to interact with the environment and establish social bonds. With aging, smell, taste, vision, and hearing decline. Evidence suggests that accelerated impairment in sensory abilities can reflect a shift from healthy to pathological aging, including the development of Alzheimer's disease (AD) and other neurological disorders. While the drivers of early sensory alteration in AD are not elucidated, insults such as trauma and infections can affect sensory function. Herein, we review the involvement of the major head and neck sensory systems in AD, with emphasis on microbes exploiting sensory pathways to enter the brain (the "gateway" hypothesis) and the potential feedback loop by which sensory function may be impacted by central nervous system infection. We emphasize detection of sensory changes as first-line surveillance in senior adults to identify and remove potential insults, like microbial infections, that could precipitate brain pathology.
Collapse
Affiliation(s)
- Praveen Bathini
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
| | | | - Brian J Balin
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
| | - Lynn Bimler
- Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
| | - David B Corry
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
- Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Biology of Inflammation Center, and the Michael E. DeBakey VA Center for Translational Research in Inflammatory Diseases, Baylor College of Medicine, Houston, Texas, USA
- Department of Pathology and Immunology, Dan L. Duncan Comprehensive Cancer Center, Biology of Inflammation Center, and the Michael E. DeBakey VA Center for Translational Research in Inflammatory Diseases, Baylor College of Medicine, Houston, Texas, USA
| | - Davangere P Devanand
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Department of Psychiatry and Neurology, Irving Medical Center, Columbia University, New York, USA
| | - Richard L Doty
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Smell and Taste Center, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Garth D Ehrlich
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Center for Genomic Sciences, Institute for Molecular Medicine and Infectious Disease, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA
| | - William A Eimer
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Charlestown, Massachusetts, USA
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
- Harvard Medical School, Harvard University, Cambridge, Massachusetts, USA
| | - Tamas Fulop
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Department of Medicine, Division of Geriatrics, Faculty of Medicine and Health Sciences, Research Center on Aging, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - David L Hahn
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
| | - Christine J Hammond
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
| | - Joseph Infanti
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Division of Research, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
| | - Ruth Itzhaki
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Institute of Population Ageing, University of Oxford, Oxford, United Kingdom
| | - Richard Lathe
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Division of Infection Medicine, University of Edinburgh Medical School, Edinburgh, United Kingdom
| | - Christopher Scott Little
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
| | - Rima McLeod
- Departments of Ophthalmology and Visual Sciences, University of Chicago, Chicago, Illinois, USA
- Department of Pediatrics Infectious Diseases, University of Chicago, Chicago, Illinois, USA
| | - Shima T Moein
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Smell and Taste Center, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Amy R Nelson
- Department of Physiology and Cell Biology, University of South Alabama, Mobile, Alabama, USA
| | - George Perry
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
- Department of Biology, The University of Texas at San Antonio, San Antonio, Texas, USA
| | - Or A Shemesh
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
- Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Rudolph E Tanzi
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Charlestown, Massachusetts, USA
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
- Harvard Medical School, Harvard University, Cambridge, Massachusetts, USA
| | - Wilmore C Webley
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
- Department of Microbiology, University of Massachusetts, Amherst, Massachusetts, USA
| | - Nikki M Schultek
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
| | - Lavinia Alberi Auber
- The Alzheimer's Pathobiome Initiative (AlzPI), Wake Forest, North Carolina, USA
- BrainFit4Life, Fribourg, Switzerland
- Intracell Research Group, LLC, Wake Forest, North Carolina, USA
- Department of Medicine, University of Fribourg, Fribourg, Switzerland
- VitalizeDx, Epalinges, Switzerland
- VitalizeDx Eu, Trieste, Italy
| |
Collapse
|
17
|
Tepedino MF, Avallone AR, Abate F, Serio M, Caterino M, Erro R, Pellecchia MT, Barone P, Picillo M. Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients. Neurol Sci 2024; 45:4335-4340. [PMID: 38639893 PMCID: PMC11306440 DOI: 10.1007/s10072-024-07533-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Accepted: 04/12/2024] [Indexed: 04/20/2024]
Abstract
INTRODUCTION Alterations in metabolic status, body composition, and food intake are present in all neurodegenerative diseases. Aim of this study was to detect the progression of these changes in Progressive Supranuclear Palsy (PSP). METHODS We conducted a longitudinal study of 15 patients with PSP. The assessments were performed at baseline (T0) and after 7(IQR = 5) months of follow-up (T1). We collected anthropometric measures including body weight, height, body mass index and waist circumference, metabolic parameters through indirect calorimeters, body composition using bioimpedance analysis, and dietary habits with a validated questionnaire. PSP-rating scale (PSP-rs) was used to evaluate disease severity and dysphagia. RESULTS The majority of patients (66.66%) presented PSP-Richardson Syndrome and 33.33% the other variant syndromes of the disease. At T1 there was a decrease in intake of total daily calories (p < 0.001), proteins (p < 0.001), fibers (p = 0.001), calcium (p = 0.008), iron (p < 0.001), zinc (0.034), vitamin E (p = 0.006) and folates (p = 0.038) compared to T0. No other changes were found. As for T1 data, no significant differences were shown according to disease phenotypes or the presence of clinically significant dysphagia for solids. CONCLUSIONS Within a mid-term follow up, PSP patients presented reduced caloric and proteins intake regardless the presence of dysphagia. The PSP-rs is likely not adequate to assess dysphagia, which should be investigated by specific clinical scales or instrumental examinations. With the goal of maintaining adequate nutritional status, the administration of protein and vitamin supplements should be considered even in the absence of dysphagia evidenced by the rating scales.
Collapse
Affiliation(s)
- Maria Francesca Tepedino
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Anna Rosa Avallone
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Filomena Abate
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Marina Serio
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Miriam Caterino
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Roberto Erro
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Maria Teresa Pellecchia
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Paolo Barone
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - Marina Picillo
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Via Allende, 84081, Baronissi, Salerno, Italy.
| |
Collapse
|
18
|
de Oliveira GD, Vicente LCC, Mourão AM, Dos Santos SHGP, Silva UM, Friche AADL, Bicalho MAC. Screening for dysphagia in older people with dementia: Evidence of validity based on internal structure and reliability of the Caregiver Questionnaire - RaDID-QC. Clinics (Sao Paulo) 2024; 79:100440. [PMID: 39126875 PMCID: PMC11369375 DOI: 10.1016/j.clinsp.2024.100440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2024] [Revised: 06/10/2024] [Accepted: 06/16/2024] [Indexed: 08/12/2024] Open
Abstract
OBJECTIVE To identify internal structure validity evidence of a dysphagia screening questionnaire for caregivers of older adults with Alzheimer's disease dementia and/or vascular dementia. METHODS The 24-question Dysphagia Screening in Older Adults with Dementia - Caregiver Questionnaire (RaDID-QC) was administered by interviewing 170 caregivers of older people with dementia, selected by convenience at the Outpatient Reference Center for Older People. Exploratory Factor Analysis (EFA) was used to assess the internal structure validity of the questionnaire, and Cronbach's alpha was used to analyze reliability. Questions with factor loadings lower than 0.45 in magnitude were removed from the final questionnaire. Multivariate multiple linear regression was used to assess the percentage of variance explained by the remaining questions. RESULTS Kayser-Meyer-Olkin (KMO) and Bartlett's tests suggested that the questionnaire was adequate for EFA. Principal Component Analysis (PCA) suggested that 12 components captured at least 75 % of the total variance. The corresponding 12-factor EFA model showed a statistically significant fit, and 15 out of the 24 questions had factor loadings greater than 0.45. Cronbach's alpha was 0.74 for the 15 questions, which explained 71 % of the total variance in the complete dataset. The questionnaire has adequate internal structure validity and good reliability. Based on EFA, RaDID-QC decreased from 24 to 15 questions. Other internal validity and reliability parameters will be obtained by administering the questionnaire to larger target populations. CONCLUSION The RaDID-QC applied to caregivers of older adults with dementia due to Alzheimer's disease and/or vascular dementia produced valid and reliable responses to screen dysphagia signs and symptoms.
Collapse
Affiliation(s)
| | - Laélia Cristina Caseiro Vicente
- Department of Speech-Language-Hearing Sciences of the Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
| | - Aline Mansueto Mourão
- Department of Speech-Language-Hearing Sciences of the Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
| | | | - Uriel Moreira Silva
- Department of Statistics (DEST), of ICEx at the Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil
| | - Amélia Augusta de Lima Friche
- Department of Speech-Language-Hearing Sciences of the Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
| | - Maria Aparecida Camargos Bicalho
- Department of Medicine of the Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil; Member of the National Institute for Responsible Neurotechnology (INCT Neurotec-R). Geriatrician at the Jenny de Andrade Faria Reference Center for the elderly - University Hospital of the Universidade Federal de Minas Gerais, Brazil
| |
Collapse
|
19
|
Ulugut H, Bertoux M, Younes K, Montembeault M, Fumagalli GG, Samanci B, Illán‐Gala I, Kuchcinski G, Leroy M, Thompson JC, Kobylecki C, Santillo AF, Englund E, Waldö ML, Riedl L, Van den Stock J, Vandenbulcke M, Vandenberghe R, Laforce Jr R, Ducharme S, Pressman PS, Caramelli P, de Souza LC, Takada LT, Gurvit H, Hansson O, Diehl‐Schmid J, Galimberti D, Pasquier F, Miller BL, Scheltens P, Ossenkoppele R, van der Flier WM, Barkhof F, Fox NC, Sturm VE, Miyagawa T, Whitwell JL, Boeve B, Rohrer JD, Gorno‐Tempini ML, Josephs KA, Snowden J, Warren JD, Rankin KP, Pijnenburg YAL. Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study. Alzheimers Dement 2024; 20:5647-5661. [PMID: 38982845 PMCID: PMC11350044 DOI: 10.1002/alz.14076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 04/15/2024] [Accepted: 05/26/2024] [Indexed: 07/11/2024]
Abstract
INTRODUCTION Although frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance has been recognized, a uniform description of the syndrome is still missing. This multicenter study aims to establish a cohesive clinical phenotype. METHODS Retrospective clinical data from 18 centers across 12 countries yielded 360 FTD patients with predominant RATL atrophy through initial neuroimaging assessments. RESULTS Common symptoms included mental rigidity/preoccupations (78%), disinhibition/socially inappropriate behavior (74%), naming/word-finding difficulties (70%), memory deficits (67%), apathy (65%), loss of empathy (65%), and face-recognition deficits (60%). Real-life examples unveiled impairments regarding landmarks, smells, sounds, tastes, and bodily sensations (74%). Cognitive test scores indicated deficits in emotion, people, social interactions, and visual semantics however, lacked objective assessments for mental rigidity and preoccupations. DISCUSSION This study cumulates the largest RATL cohort unveiling unique RATL symptoms subdued in prior diagnostic guidelines. Our novel approach, combining real-life examples with cognitive tests, offers clinicians a comprehensive toolkit for managing these patients. HIGHLIGHTS This project is the first international collaboration and largest reported cohort. Further efforts are warranted for precise nomenclature reflecting neural mechanisms. Our results will serve as a clinical guideline for early and accurate diagnoses.
Collapse
Affiliation(s)
- Hulya Ulugut
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Maxime Bertoux
- Lille Neuroscience & Cognition U1172, Univ. Lille, Inserm, CHU Lille, LiCEND & Labex DistALZLilleFrance
| | - Kyan Younes
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Stanford Neuroscience Health CenterDepartment of NeurologyStanford UniversityPalo AltoCaliforniaUSA
| | - Maxime Montembeault
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of PsychiatryDouglas Mental Health University InstituteMcGill University Health CentreMcGill UniversityMontrealQuebecCanada
| | - Giorgio G. Fumagalli
- Department of NeurologyUniversity of MilanMilanItaly
- Università degli Studi di Trento | UNITN·CIMEC ‐ Center for Mind/Brain SciencesMattarelloTrentinoItaly
| | - Bedia Samanci
- Department of NeurologyIstanbul UniversityFatihIstanbulTurkey
| | - Ignacio Illán‐Gala
- Sant Pau Memory UnitDepartment of NeurologyHospital de la Santa Creu i Sant PauBiomedical Research Institute Sant PauUniversitat Autònoma de BarcelonaBarcelonaSpain
- Centro de Investigación en Red‐Enfermedades Neurodegenerativas (CIBERNED)MadridSpain
| | - Gregory Kuchcinski
- Lille Neuroscience & Cognition U1172, Univ. Lille, Inserm, CHU Lille, LiCEND & Labex DistALZLilleFrance
| | - Melanie Leroy
- Lille Neuroscience & Cognition U1172, Univ. Lille, Inserm, CHU Lille, LiCEND & Labex DistALZLilleFrance
| | - Jennifer C. Thompson
- Cerebral Function Unit, Greater Manchester Neuroscience CentreSalford Royal NHS Foundation TrustSalfordUK
- Division of Neuroscience and Experimental PsychologyFaculty of BiologyMedicine and HealthUniversity of ManchesterSalfordManchesterUK
| | - Christopher Kobylecki
- Department of NeurologyManchester Centre for Clinical Neurosciences NHS Foundation TrustSalfordUK
- Division of NeuroscienceUniversity of ManchesterSalfordManchesterUK
| | - Alexander F Santillo
- Clinical Memory Research UnitDepartment of Clinical SciencesFaculty of MedicineLund UniversityLundSweden
| | - Elisabet Englund
- Division of PathologyDepartment of Clinical SciencesLund UniversityLundSweden
| | - Maria Landqvist Waldö
- Division of Clinical Sciences HelsingborgDepartment of Clinical Sciences LundLund UniversityLundSweden
| | - Lina Riedl
- School of MedicineDepartment of Psychiatry and PsychotherapyTechnical University of MunichMunichGermany
| | - Jan Van den Stock
- Neuropsychiatry, Department of NeurosciencesLeuven Brain InstituteLeuvenBelgium
| | | | | | - Robert Laforce Jr
- Clinique Interdisciplinaire de Mémoire (CIME)Département des Sciences NeurologiquesLaval UniversityQuebec CityCanada
| | - Simon Ducharme
- Department of PsychiatryDouglas Mental Health University InstituteMcGill University Health CentreMcGill UniversityMontrealQuebecCanada
| | - Peter S. Pressman
- Anschutz Medical CampusBehavioral Neurology SectionDepartment of NeurologyUniversity of ColoradoAuroraColoradoUSA
| | - Paulo Caramelli
- Behavioral and Cognitive Neurology UnitDepartment of Internal MedicineFaculdade de MedicinaUniversidade Federal de Minas GeraisBelo HorizonteBrazil
| | - Leonardo Cruz de Souza
- Behavioral and Cognitive Neurology UnitDepartment of Internal MedicineFaculdade de MedicinaUniversidade Federal de Minas GeraisBelo HorizonteBrazil
| | - Leonel T. Takada
- Cognitive and Behavioral UnitHospital das ClinicasDepartment of NeurologyUniversity of São Paulo Medical SchoolPacaembuSão PauloBrazil
| | - Hakan Gurvit
- Department of NeurologyIstanbul UniversityFatihIstanbulTurkey
| | - Oskar Hansson
- Clinical Memory Research UnitDepartment of Clinical SciencesFaculty of MedicineLund UniversityLundSweden
| | - Janine Diehl‐Schmid
- School of MedicineDepartment of Psychiatry and PsychotherapyTechnical University of MunichMunichGermany
- Kbo‐Inn‐Salzach‐KlinikumClinical Center for PsychiatryPsychotherapy, Psychosomatic Medicine, Geriatrics and NeurologyWasserburg/InnGermany
| | - Daniela Galimberti
- Department of BiomedicalSurgical and Dental SciencesUniversity of MilanMilanItaly
- Fondazione IRCCS Ca’ GrandaOspedale Maggiore PoliclinicoMilanItaly
| | - Florence Pasquier
- Lille Neuroscience & Cognition U1172, Univ. Lille, Inserm, CHU Lille, LiCEND & Labex DistALZLilleFrance
| | - Bruce L. Miller
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Philip Scheltens
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
| | - Rik Ossenkoppele
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
- Alzheimer Center AmsterdamDepartment of RadiologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
| | - Frederik Barkhof
- Alzheimer Center AmsterdamDepartment of RadiologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
- UCL Institutes of Neurology and Healthcare EngineeringUniversity College LondonLondonUK
| | - Nick C. Fox
- Dementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | - Virginia E. Sturm
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Toji Miyagawa
- Department of NeurologyMayo Clinic, RochesterRochesterMinnesotaUSA
| | | | - Bradley Boeve
- Department of NeurologyMayo Clinic, RochesterRochesterMinnesotaUSA
| | | | - Maria Luisa Gorno‐Tempini
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Dyslexia CenterUniversity of California San FranciscoUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Keith A. Josephs
- Department of NeurologyMayo Clinic, RochesterRochesterMinnesotaUSA
| | - Julie Snowden
- Cerebral Function Unit, Greater Manchester Neuroscience CentreSalford Royal NHS Foundation TrustSalfordUK
- Division of Neuroscience and Experimental PsychologyFaculty of BiologyMedicine and HealthUniversity of ManchesterSalfordManchesterUK
| | - Jason D. Warren
- Dementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | - Katherine P. Rankin
- Memory and Aging CenterDepartment of NeurologyUCSF Weill Institute for NeurosciencesUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Yolande A. L. Pijnenburg
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCDe BoelelaanAmsterdamThe Netherlands
| | | |
Collapse
|
20
|
Palli C, Mack S, Müller G. Development of clinical items to identify dysphagia in patients with dementia-An e-Delphi study. J Clin Nurs 2024; 33:3556-3564. [PMID: 38284459 DOI: 10.1111/jocn.17027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Revised: 01/07/2024] [Accepted: 01/15/2024] [Indexed: 01/30/2024]
Abstract
AIM To identify clinical observable items that can be used to identify dysphagia while observing a typical eating situation. DESIGN A three-round e-Delphi survey. METHODS An expert panel consisting of five nurses, eight speech language therapists and five physicians participated in this three-round e-Delphi survey from November 2022 to January 2023. Round 1 presented the results of a literature research conducted in September 2022 and an open question to the participants. The answers were analysed using the content analysis method. In the following rounds, the results were presented back to the participants with a request to rate them for usefulness. Means, standard deviations, ANOVA and Fisher's exact test were used to demonstrate the panel's opinion, level of agreement, demographic characteristics of the participants as well as differences between the professional groups in regard of the rating of the items. Methods and results are reported in accordance with the 'Guidance on Conducting and Reporting Delphi Studies' (CREDES). RESULTS The content analysis initially generated 36 items suggested by the expert panel. Seven additional items were incorporated from the literature review. In rounds 2 and 3, a 4-point Likert scale was used to rate each item and to calculate the level of agreement. The predetermined level of agreement exceeded 70% for 23 items. CONCLUSION Based on the expert opinions, it is possible for nurses to identify dysphagia in patients with dementia by using the determined 23 items while observing a typical eating situation. PATIENT OR PUBLIC CONTRIBUTIONS The expert panel contributed to the creation of this study by participating in the Delphi rounds. IMPLICATIONS FOR THE PROFESSION AND/OR PATIENT CARE The 23 items determined in this e-Delphi study enable nurses to make dietary adjustments or consult other members of the multidisciplinary team based on available evidence, enabling complications to be avoided. IMPACT What problem did the study address? This study provides evidence regarding the identification of dysphagia in patients with dementia by nurses. What were the main findings? Twenty-three items were determined by an expert panel that can be used by nurses to identify dysphagia in patients with dementia while observing a typical eating situation. Where and on whom will the research have an impact? This research will have an impact on patients with dementia and the nurses caring for them. REPORTING METHOD Methods and results are reported in accordance with the 'Guidance on Conducting and Reporting Delphi Studies' (CREDES) (Jünger et al., 2017), which promotes consistency and quality in conducting Delphi studies.
Collapse
Affiliation(s)
- Christoph Palli
- Health Care and Nursing, University of Applied Sciences FH Joanneum, Graz, Austria
- Nursing Science and Gerontology, UMIT TIROL - Private University of Health Sciences and Health Technology, Hall in Tirol, Austria
| | - Sandra Mack
- Health Care and Nursing, University of Applied Sciences FH Joanneum, Graz, Austria
| | - Gerhard Müller
- Nursing Science and Gerontology, UMIT TIROL - Private University of Health Sciences and Health Technology, Hall in Tirol, Austria
| |
Collapse
|
21
|
Le HT, Dang AK, Le LTT, Nguyen HTT, Nguyen GT, Nguyen HTT, Phan HBT, Nguyen TA, Robinson L. Nutritional status, dietary quality and eating disturbance issues among people with dementia in Vietnam: evidence of a cross-sectional study. JOURNAL OF HEALTH, POPULATION, AND NUTRITION 2024; 43:107. [PMID: 38987853 PMCID: PMC11238499 DOI: 10.1186/s41043-024-00570-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 05/17/2024] [Indexed: 07/12/2024]
Abstract
BACKGROUND Due to cognitive impairments, people with dementia (PWD) often have difficulties in eating and drinking. This study aimed to assess the nutritional status, dietary quality and eating disturbance issues among PWD in Vietnam. METHODS We conducted a cross-sectional study at the Vietnamese National Geriatric Hospital from April to December 2022. We used Mini-Mental State Exam (MMSE) to classify the severity levels of dementia. Mini Nutritional Assessment (MNA), 24-hour recall, eating disturbance questionnaires, and anthropometric indicators were used to evaluate the nutritional status, dietary quality, and eating disorders of study subjects. RESULTS Overall, among 63 study participants, 74.6 per cent of PWD were at risk of or having malnutrition. By dementia classification according to MMSE scale, people with moderate and severe dementia accounted for 53.3 per cent of those who met the recommended energy levels, compared to 42.4 per cent of people with mild dementia and normal people. In the above two groups, around three per cent of participants reached the recommended amount of fibre. Calcium (50-70%), vitamin A (80-90%), and D (90%) were found to be the most severe deficiency forms of minerals and vitamins in both male and female participants. The majority of participants (90.5%) had at least one form of eating disorders with the most frequent issue being appetite changes (76.2%) and swallowing issues (50.8%). CONCLUSIONS PWD in our sample frequently experienced malnutrition, a lack of essential nutrients, difficulties swallowing, changes in eating habits and appetite. It is neccesary to early screen and assess nutritional status and swallowing disturbance in PWD, and instruct their caregivers to prepare nutritious meals for them.
Collapse
Affiliation(s)
- Huong Thi Le
- School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, 100000, Vietnam
| | - Anh Kim Dang
- School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, 100000, Vietnam
- Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, 20 Cornwall Street, Woolloongabba, Brisbane, Australia
| | - Linh Thao Thi Le
- School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, 100000, Vietnam.
| | - Ha Thu Thi Nguyen
- School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, 100000, Vietnam
| | - Giang Thu Nguyen
- Population Health Sciences Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK
| | - Huong Thi Thu Nguyen
- Department of Geriatrics, Hanoi Medical University, Hanoi, Vietnam
- Scientific Research Department, National Geriatric Hospital, Hanoi, Vietnam
| | - Hanh Bich Thi Phan
- Faculty of Dentistry, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam
| | - Tuan Anh Nguyen
- Social Gerontology Division, National Ageing Research Institute, Melbourne, VIC, Australia
- Department of Psychological Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia
- Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia
| | - Louise Robinson
- Population Health Sciences Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK
| |
Collapse
|
22
|
Lee K, Kim S, Liu W. Assessing eating ability and mealtime behaviors of persons living with dementia: A systematic review of instruments. Geriatr Nurs 2024; 58:76-86. [PMID: 38781628 DOI: 10.1016/j.gerinurse.2024.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2024] [Revised: 04/29/2024] [Accepted: 05/06/2024] [Indexed: 05/25/2024]
Abstract
This systematic review aimed to describe the characteristics of instruments that assess eating ability and/or mealtime behaviors in persons living with dementia, and evaluate their psychometric properties. Five databases were searched for relevant records between 1/1/1980 and 5/25/2023. Records included instruments assessing eating ability and/or mealtime behaviors of people with dementia. The psychometric quality of the instruments was evaluated using the Psychometric Assessment for Self-report and Observational Tools (PAT). 45 eligible instruments were identified from 115 records. While 38 instruments were scored as having low psychometric quality, 7 had moderate quality. Edinburgh Feeding Evaluation in Dementia (EdFED), Mealtime Difficulty Scale for older adults with Dementia (MDSD), and Dementia Hyperphagic Behavior Scale (DHBS) were scored as having the highest quality (total PAT score = 9). Further refinement of existing instruments and additional psychometric testing in larger, diverse samples will improve pragmatic use in dementia mealtime care research and practice.
Collapse
Affiliation(s)
- Kyuri Lee
- University of Iowa College of Nursing, 50 Newton Road, Iowa City, Iowa 52242, United States.
| | - Sohyun Kim
- University of Texas at Arlington College of Nursing and Health Innovation, 411 S. Nedderman Drive, Arlington, Texas 76019, United States
| | - Wen Liu
- University of Iowa College of Nursing, 50 Newton Road, Iowa City, Iowa 52242, United States
| |
Collapse
|
23
|
Rouse MA, Binney RJ, Patterson K, Rowe JB, Lambon Ralph MA. A neuroanatomical and cognitive model of impaired social behaviour in frontotemporal dementia. Brain 2024; 147:1953-1966. [PMID: 38334506 PMCID: PMC11146431 DOI: 10.1093/brain/awae040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 12/21/2023] [Accepted: 01/21/2024] [Indexed: 02/10/2024] Open
Abstract
Impaired social cognition is a core deficit in frontotemporal dementia (FTD). It is most commonly associated with the behavioural-variant of FTD, with atrophy of the orbitofrontal and ventromedial prefrontal cortex. Social cognitive changes are also common in semantic dementia, with atrophy centred on the anterior temporal lobes. The impairment of social behaviour in FTD has typically been attributed to damage to the orbitofrontal cortex and/or temporal poles and/or the uncinate fasciculus that connects them. However, the relative contributions of each region are unresolved. In this review, we present a unified neurocognitive model of controlled social behaviour that not only explains the observed impairment of social behaviours in FTD, but also assimilates both consistent and potentially contradictory findings from other patient groups, comparative neurology and normative cognitive neuroscience. We propose that impaired social behaviour results from damage to two cognitively- and anatomically-distinct components. The first component is social-semantic knowledge, a part of the general semantic-conceptual system supported by the anterior temporal lobes bilaterally. The second component is social control, supported by the orbitofrontal cortex, medial frontal cortex and ventrolateral frontal cortex, which interacts with social-semantic knowledge to guide and shape social behaviour.
Collapse
Affiliation(s)
- Matthew A Rouse
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK
| | - Richard J Binney
- Cognitive Neuroscience Institute, Department of Psychology, School of Human and Behavioural Sciences, Bangor University, Bangor LL57 2AS, UK
| | - Karalyn Patterson
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK
| | - James B Rowe
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK
- Department of Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0SZ, UK
| | | |
Collapse
|
24
|
Fujioka Y, Kawai K, Endo K, Ishibashi M, Iwade N, Tuerde D, Kaibuchi K, Yamashita T, Yamanaka A, Katsuno M, Watanabe H, Sobue G, Ishigaki S. Stress-impaired reward pathway promotes distinct feeding behavior patterns. Front Neurosci 2024; 18:1349366. [PMID: 38784098 PMCID: PMC11111882 DOI: 10.3389/fnins.2024.1349366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 04/18/2024] [Indexed: 05/25/2024] Open
Abstract
Although dietary behaviors are affected by neuropsychiatric disorders, various environmental conditions can have strong effects as well. We found that mice under multiple stresses, including social isolation, intermittent high-fat diet, and physical restraint, developed feeding behavior patterns characterized by a deviated bait approach (fixated feeding). All the tested stressors affected dopamine release at the nucleus accumbens (NAcc) shell and dopamine normalization reversed the feeding defects. Moreover, inhibition of dopaminergic activity in the ventral tegmental area that projects into the NAcc shell caused similar feeding pattern aberrations. Given that the deviations were not consistently accompanied by changes in the amount consumed or metabolic factors, the alterations in feeding behaviors likely reflect perturbations to a critical stress-associated pathway in the mesolimbic dopamine system. Thus, deviations in feeding behavior patterns that reflect reward system abnormalities can be sensitive biomarkers of psychosocial and physical stress.
Collapse
Affiliation(s)
- Yusuke Fujioka
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Kaori Kawai
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan
| | - Kuniyuki Endo
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Minaka Ishibashi
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Nobuyuki Iwade
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Dilina Tuerde
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Kozo Kaibuchi
- Research Project for Neural and Tumor Signaling, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Takayuki Yamashita
- Department of Physiology, School of Medicine, Fujita Health University, Toyoake, Japan
| | - Akihiro Yamanaka
- Chinese Institute for Brain Research, Beijing (CIBR), Beijing, China
| | - Masahisa Katsuno
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan
| | - Hirohisa Watanabe
- Department of Neurology, School of Medicine, Fujita Health University, Toyoake, Japan
| | - Gen Sobue
- Aichi Medical University, Nagakute, Japan
| | - Shinsuke Ishigaki
- Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
| |
Collapse
|
25
|
Huang M, Landin-Romero R, Matis S, Dalton MA, Piguet O. Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia. J Neurol 2024; 271:2509-2520. [PMID: 38265470 PMCID: PMC11055736 DOI: 10.1007/s00415-023-12172-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 12/20/2023] [Accepted: 12/23/2023] [Indexed: 01/25/2024]
Abstract
Amygdala atrophy has been found in frontotemporal dementia (FTD), yet the specific changes of its subregions across different FTD phenotypes remain unclear. The aim of this study was to investigate the volumetric alterations of the amygdala subregions in FTD phenotypes and how they evolve with disease progression. Patients clinically diagnosed with behavioral variant FTD (bvFTD) (n = 20), semantic dementia (SD) (n = 20), primary nonfluent aphasia (PNFA) (n = 20), Alzheimer's disease (AD) (n = 20), and 20 matched healthy controls underwent whole brain structural MRI. The patient groups were followed up annually for up to 3.5 years. Amygdala nuclei were segmented using FreeSurfer, corrected by total intracranial volumes, and grouped into the basolateral, superficial, and centromedial subregions. Linear mixed effects models were applied to identify changes in amygdala subregional volumes over time. At baseline, bvFTD, SD, and AD displayed global amygdala volume reduction, whereas amygdala volume appeared to be preserved in PNFA. Asymmetrical amygdala atrophy (left > right) was most pronounced in SD. Longitudinally, SD and PNFA showed greater rates of annual decline in the right basolateral and superficial subregions compared to bvFTD and AD. The findings provide comprehensive insights into the differential impact of FTD pathology on amygdala subregions, revealing distinct atrophy patterns that evolve over disease progression. The characterization of amygdala subregional involvement in FTD and their potential role as biomarkers carry substantial clinical implications.
Collapse
Affiliation(s)
- Mengjie Huang
- School of Psychology, The University of Sydney, Camperdown, NSW, 2050, Australia
- Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, NSW, 2050, Australia
| | - Ramon Landin-Romero
- Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, NSW, 2050, Australia
- School of Health Sciences, The University of Sydney, Camperdown, NSW, 2050, Australia
| | - Sophie Matis
- Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, NSW, 2050, Australia
- School of Health Sciences, The University of Sydney, Camperdown, NSW, 2050, Australia
| | - Marshall A Dalton
- School of Psychology, The University of Sydney, Camperdown, NSW, 2050, Australia
- Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, NSW, 2050, Australia
| | - Olivier Piguet
- School of Psychology, The University of Sydney, Camperdown, NSW, 2050, Australia.
- Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, NSW, 2050, Australia.
| |
Collapse
|
26
|
Mollah SA, Nayak A, Barhai S, Maity U. A comprehensive review on frontotemporal dementia: its impact on language, speech and behavior. Dement Neuropsychol 2024; 18:e20230072. [PMID: 38659629 PMCID: PMC11041917 DOI: 10.1590/1980-5764-dn-2023-0072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 11/26/2023] [Accepted: 12/26/2023] [Indexed: 04/26/2024] Open
Abstract
Frontotemporal dementia (FTD) is a progressive neurodegenerative disorder defined by the selective deterioration of the frontal and temporal lobes of the brain. This comprehensive review explored the effect of FTD on language, speech, and behavior. Early symptoms include difficulty in word finding, reduced speech output, and comprehension deficits, often leading to aphasia. The study discussed the profound behavioral changes observed in FTD patients, including apathy, disinhibition, compulsive behaviors, and loss of empathy, the importance of an accurate and early diagnosis, and its challenges. We even reviewed the potential for targeted therapies and the essential role of multidisciplinary care in managing the language, speech, and behavioral aspects of FTD. By examining objective data and comprehensive research on the subject, this study offers valuable insights into FTD's profound effects on language, speech, and behavior, assisting in improved clinical management and potential therapeutic strategies for this devastating condition.
Collapse
Affiliation(s)
- Sha Abbas Mollah
- Rajiv Gandhi University, Health Sciences Karnataka, East West College of Pharmacy, Department of Pharmacy Practice - Bengaluru Karnataka, India
| | - Aditya Nayak
- Rajiv Gandhi University, Health Sciences Karnataka, East West College of Pharmacy, Department of Pharmacy Practice - Bengaluru Karnataka, India
| | - Swapna Barhai
- Rajiv Gandhi University, Health Sciences Karnataka, East West College of Pharmacy, Department of Pharmacy Practice - Bengaluru Karnataka, India
| | - Uddip Maity
- Rajiv Gandhi University, Health Sciences Karnataka, East West College of Pharmacy, Department of Pharmacy Practice - Bengaluru Karnataka, India
| |
Collapse
|
27
|
Dericioglu D, Methven L, Clegg ME. Understanding age-related changes: exploring the interplay of protein intake, physical activity and appetite in the ageing population. Proc Nutr Soc 2024:1-13. [PMID: 38557431 DOI: 10.1017/s0029665124002192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
Globally, we are currently facing a rapid demographic shift leading to an increase in the proportion of older adults within the population. This raises concerns about the potential increase in age-related diseases and their impact on our ability to provide adequate health and end-of-life care. To apply appropriate interventions, understanding the changes that happen with ageing becomes essential. Ageing is often accompanied by a decrease in appetite and physical activity, which may lead to malnutrition, resulting in decreased muscle mass, physical capabilities and independence. To preserve muscle mass, older adults are advised to increase protein intake and physical activity. However, protein's high satiating effect may cause reduced energy intake. Physical activity is also advised to maintain or enhance older adult's appetite. This review paper aims to discuss appetite-related changes that occur with ageing and their consequences. In particular, it will focus on investigating the relationship between protein intake and physical activity and their impact on appetite and energy intake in the ageing population. Recent studies suggest that physical activity might contribute to maintaining or enhancing appetite in older adults. Nevertheless, establishing a definitive consensus on the satiating effect of protein in ageing remains a work in progress, despite some promising results in the existing literature.
Collapse
Affiliation(s)
- Dilara Dericioglu
- Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Whiteknights, ReadingRG6 6DZ, UK
- Institute of Food, Nutrition and Health, University of Reading, Whiteknights, Reading RG6 6EU, UK
| | - Lisa Methven
- Institute of Food, Nutrition and Health, University of Reading, Whiteknights, Reading RG6 6EU, UK
- Food Research Group, Department of Food and Nutritional Sciences, University of Reading,Whiteknights, Reading RG6 6DZ, UK
| | - Miriam E Clegg
- Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Whiteknights, ReadingRG6 6DZ, UK
- Institute of Food, Nutrition and Health, University of Reading, Whiteknights, Reading RG6 6EU, UK
- School of Food and Nutritional Sciences, University College Cork, Cork, Ireland
| |
Collapse
|
28
|
Zhu L, Lei M, Tan L, Zou M. Sex difference in the association between BMI and cognitive impairment in Chinese older adults. J Affect Disord 2024; 349:39-47. [PMID: 38190856 DOI: 10.1016/j.jad.2024.01.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 11/30/2023] [Accepted: 01/03/2024] [Indexed: 01/10/2024]
Abstract
BACKGROUND The association between body mass index (BMI) and cognitive impairment (CI) has been the subject of extensive research, yet the precise dose-response effects remain undefined. METHODS Older adults were selected from the 2011/2012 survey at baseline and the new recruits from the 2014 and 2018 waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS). Multiple logistic regression models were used to evaluate the association between BMI categories and CI, and Restricted Cubic Spline (RCS) was used to explore the nonlinear relationship between BMI and CI. RESULTS The study included 29,380 older adults aged from 65 to 117 years, with an average age of 82 years. Of these, 13,465 were men, and 5359 exhibited cognitive impairment. The logistic model indicated that in female participants, being underweight was positively correlated with CI (OR:1.32; 95%CI 1.20-1.46), whereas being overweight was inversely correlated with CI (OR:0.86; 95%CI 0.75-0.99), and we didn't find any association between BMI category and CI in male participants. RCS modeling revealed a U-shaped relationship between BMI and CI. When stratified by sex, men exhibited a similar trend, with the lowest risk at a BMI of 22.774 kg/ m2, while women had the lowest risk of CI at a BMI of 24.817 kg/ m2. LIMITATION This was a cross-sectional study, it cannot provide information on causal relationships. CONCLUSION A U-shaped relationship was observed between BMI and CI in older adults, more pronounced in the male population, suggesting that male older adults may need to manage their BMI more rigorously.
Collapse
Affiliation(s)
- Lin Zhu
- Wuhan Pulmonary Hospital, Wuhan, China
| | - Mei Lei
- Wuhan Pulmonary Hospital, Wuhan, China
| | - Li Tan
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| | - Mingjun Zou
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| |
Collapse
|
29
|
Ye J, Wu C, Chen J, Wang H, Pan Y, Huang X, Wu J, Zhong X, Zhou H, Wang W, Wu S, Zhou T, Wang L, Lu P, Ruan C, Guo J, Ning Y, Xiao A. Effectiveness of nurse-delivered stepwise swallowing training on dysphagia in patients with Alzheimer's disease: A multi-center randomized controlled trial. Int J Nurs Stud 2024; 150:104649. [PMID: 38070229 DOI: 10.1016/j.ijnurstu.2023.104649] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 11/15/2023] [Accepted: 11/16/2023] [Indexed: 01/23/2024]
Abstract
BACKGROUND Although swallowing exercises are a fundamental treatment for dysphagia, few studies have evaluated the effectiveness of swallowing training in patients with Alzheimer's disease. METHODS We recruited 93 patients with Alzheimer's disease from three hospitals in Guangdong, China. This was a parallel armed randomized controlled trial that randomly assigned patients to intervention (n = 48) and control (n = 45) groups. The intervention group adopted systematic stepwise swallowing training for four weeks based on routine dysphagia care. The control group implemented routine dysphagia care, including diet and posture management and health education about swallowing dysfunction. The swallowing function was the primary outcome, which was assessed using the Water Swallowing Test and Standard Swallowing Assessment. An abnormal eating behavior questionnaire was used to assess the incidence of aberrant eating behavior in patients with Alzheimer's disease. The Mini-Nutritional Assessment Short Form and Barthel index were adopted to evaluate the nutritional status and ability to carry out daily activities between groups. SPSS software was used to perform the chi-square test, t-test, and generalized estimation equation for data analysis. RESULTS We analyzed the effects of the stepwise swallowing training program using the generalized estimating equation method. The intervention group exhibited greater improvements in their swallowing function (Water Swallowing Test: β = -3.133, 95 % CI: -4.113, -2.154, P < 0.001; Standard Swallowing Assessment: β = -5.813, 95 % CI: -7.782, -3.844, P < 0.001), abnormal eating behaviors (abnormal eating behavior questionnaire: β = -13.324, 95 % CI: -21.643, -5.005, P = 0.002), daily function (Barthel index: β = 11.280, 95 % CI: 4.021, 18.540, P = 0.002), and nutritional status (Mini-Nutritional Assessment Short Form: β = 2.402, 95 % CI: 1.313, 3.490, P < 0.001) over time than the routine-care group in the fourth week. CONCLUSIONS Stepwise swallowing training is a safe and effective intervention for managing dysphagia and other related symptoms in patients with Alzheimer's disease.
Collapse
Affiliation(s)
- Junrong Ye
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Chenxin Wu
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Jiao Chen
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Haoyun Wang
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Yuanxin Pan
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Xingxiao Huang
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jialan Wu
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Nursing, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Xiaomei Zhong
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Huarong Zhou
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Wen Wang
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Shengwei Wu
- Department of Traditional Chinese Medicine, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
| | - Tingwei Zhou
- School of Nursing, Guangzhou Medical University, Guangzhou, China
| | - Li Wang
- Department of Nursing, Third People's Hospital of Jiangmen, Guangdong, China
| | - Peilan Lu
- Department of Neurology, Third People's Hospital of Jiangmen, Guangdong, China
| | - Chunrui Ruan
- Department of Geriatrics, Third People's Hospital of Jiangmen, Guangdong, China
| | - Jianxiong Guo
- Department of Chronic Diseases, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China
| | - Yuping Ning
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.
| | - Aixiang Xiao
- Geriatric Neuroscience Center, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Nursing, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.
| |
Collapse
|
30
|
Sharma S, A. Halim NA, Maniam P. Caregiver Experiences with Dementia-Related Feeding/Eating Difficulties. Healthcare (Basel) 2024; 12:133. [PMID: 38255022 PMCID: PMC10815734 DOI: 10.3390/healthcare12020133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 12/05/2023] [Accepted: 12/06/2023] [Indexed: 01/24/2024] Open
Abstract
This cross-sectional study explores caregivers' perceptions of feeding/eating difficulties in persons living with dementia, their support provisions, and the associated burdens. Cognitive decline, behavioral symptoms, and physical issues contribute to the deterioration of feeding/eating activities in people with dementia. Inadequate support during mealtimes has adverse consequences. This study includes 31 caregivers who completed an online questionnaire with three sections: sociodemographic information, feeding/eating problems and required support for individuals with dementia, and caregiver burden and distress. The questions on feeding and eating problems were adapted from the Appetite and Eating Habits Questionnaire (APEHQ). The results show that nearly all persons living with dementia had symptoms of feeding/eating problems, requiring caregiver support, ranging from verbal assistance to full physical assistance. The caregivers reported high distress, which was positively correlated with dementia severity. The findings emphasize the importance of raising caregiver awareness about dementia's impact on eating behavior, identifying effective mealtime care strategies, meeting nutritional needs, and emphasizing personal self-care. This research provides insights for healthcare professionals to develop targeted interventions, alleviate caregiver burden, improve mealtime experiences, and ensure adequate nutrition for persons living with dementia.
Collapse
Affiliation(s)
- Shobha Sharma
- Speech Sciences Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia
- Centre for Healthy Ageing and Wellness (H-Care), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia
| | - Nur Atiqah A. Halim
- Speech Sciences Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia
| | - Puspa Maniam
- Department of Otorhinolaryngology, Kuala Lumpur General Hospital, Kuala Lumpur 50586, Malaysia
| |
Collapse
|
31
|
Hardy CJD, Taylor‐Rubin C, Taylor B, Harding E, Gonzalez AS, Jiang J, Thompson L, Kingma R, Chokesuwattanaskul A, Walker F, Barker S, Brotherhood E, Waddington C, Wood O, Zimmermann N, Kupeli N, Yong KXX, Camic PM, Stott J, Marshall CR, Oxtoby NP, Rohrer JD, Volkmer A, Crutch SJ, Warren JD. Symptom-led staging for semantic and non-fluent/agrammatic variants of primary progressive aphasia. Alzheimers Dement 2024; 20:195-210. [PMID: 37548125 PMCID: PMC10917001 DOI: 10.1002/alz.13415] [Citation(s) in RCA: 22] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 07/07/2023] [Accepted: 07/10/2023] [Indexed: 08/08/2023]
Abstract
INTRODUCTION Here we set out to create a symptom-led staging system for the canonical semantic and non-fluent/agrammatic variants of primary progressive aphasia (PPA), which present unique diagnostic and management challenges not well captured by functional scales developed for Alzheimer's disease and other dementias. METHODS An international PPA caregiver cohort was surveyed on symptom development under six provisional clinical stages and feedback was analyzed using a mixed-methods sequential explanatory design. RESULTS Both PPA syndromes were characterized by initial communication dysfunction and non-verbal behavioral changes, with increasing syndromic convergence and functional dependency at later stages. Milestone symptoms were distilled to create a prototypical progression and severity scale of functional impairment: the PPA Progression Planning Aid ("PPA-Squared"). DISCUSSION This work introduces a symptom-led staging scheme and functional scale for semantic and non-fluent/agrammatic variants of PPA. Our findings have implications for diagnostic and care pathway guidelines, trial design, and personalized prognosis and treatment for PPA. HIGHLIGHTS We introduce new symptom-led perspectives on primary progressive aphasia (PPA). The focus is on non-fluent/agrammatic (nfvPPA) and semantic (svPPA) variants. Foregrounding of early and non-verbal features of PPA and clinical trajectories is featured. We introduce a symptom-led staging scheme for PPA. We propose a prototype for a functional impairment scale, the PPA Progression Planning Aid.
Collapse
Affiliation(s)
- Chris J. D. Hardy
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Cathleen Taylor‐Rubin
- Uniting War Memorial HospitalSydneyAustralia
- Faculty of MedicineHealth and Human SciencesMacquarie UniversitySydneyAustralia
| | - Beatrice Taylor
- Centre for Medical Image ComputingDepartment of Computer ScienceUCLLondonUK
| | - Emma Harding
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | | | - Jessica Jiang
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | | | | | - Anthipa Chokesuwattanaskul
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
- Division of NeurologyDepartment of Internal MedicineKing Chulalongkorn Memorial HospitalBangkokThailand
- Cognitive Clinical and Computational Neuroscience Research UnitFaculty of MedicineChulalongkorn UniversityBangkokThailand
| | | | - Suzie Barker
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Emilie Brotherhood
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Claire Waddington
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Olivia Wood
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Nikki Zimmermann
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Nuriye Kupeli
- Marie Curie Palliative Care Research DepartmentDivision of PsychiatryUCLLondonUK
| | - Keir X. X. Yong
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Paul M. Camic
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Joshua Stott
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
- ADAPT LabResearch Department of ClinicalEducational and Health PsychologyUCLLondonUK
| | | | - Neil P. Oxtoby
- Centre for Medical Image ComputingDepartment of Computer ScienceUCLLondonUK
| | - Jonathan D. Rohrer
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| | - Anna Volkmer
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
- Psychology and Language Sciences (PALS)UCLLondonUK
| | | | - Jason D. Warren
- Dementia Research CentreUCL Queen Square Institute of NeurologyUCLLondonUK
| |
Collapse
|
32
|
Burdick R, Bayne D, Hitchcock M, Gilmore-Bykovskyi A, Shune S, Rogus-Pulia N. The Impact of Modifiable Preoral Factors on Swallowing and Nutritional Outcomes in Healthy Adults: A Scoping Review. JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH : JSLHR 2023; 66:4860-4895. [PMID: 37931134 DOI: 10.1044/2023_jslhr-23-00062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2023]
Abstract
PURPOSE Swallowing has previously been characterized as consisting of four phases; however, it has become apparent that these four phases are not truly discrete and may be influenced by factors occurring prior to bolus entrance into the oral cavity (i.e., preoral factors). Still, the relationship between these factors and swallowing remains poorly understood. The aim of this review was to synthesize and characterize the literature pertaining to the influence of preoral factors on swallowing and nutritional outcomes in healthy individuals. METHOD We performed a scoping review, searching the databases of PubMed, CINAHL, Cochrane, and Scopus. Search terms included those related to swallowing, experience of preoral factors, and exclusionary terminology to reduce animal and pediatric literature. Our initial search revealed 5,560 unique articles, of which 153 met our inclusionary criteria and were accepted into the review. RESULTS Of the accepted articles, 78% were focused exclusively on nutritional outcomes, 17% were focused on both swallowing and nutritional outcomes, and 5% were focused on solely swallowing outcomes. Of the preoral factors examined, 99% were exteroceptive in nature (17% olfactory, 44% visual, 21% auditory, 7% tactile, 11% other), while 1% were proprioceptive in nature. CONCLUSIONS This review supports the influence of preoral factors on swallowing and nutritional outcomes. However, there is a large emphasis on the visual modality and on nutritional outcomes. Nearly none of the literature found in this review directly measured swallowing safety, efficiency, or physiology. Future work will benefit from a larger focus on proprioceptive preoral factors as they relate to swallowing outcomes.
Collapse
Affiliation(s)
- Ryan Burdick
- Division of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison
- Geriatric Research Education and Clinical Center, William S. Middleton Veterans' Hospital, Madison, WI
| | - David Bayne
- Communication Disorders and Sciences Program, University of Oregon, Eugene
| | | | - Andrea Gilmore-Bykovskyi
- BerbeeWalsh Department of Emergency Medicine, School of Medicine and Public Health, University of Wisconsin-Madison
| | - Samantha Shune
- Communication Disorders and Sciences Program, University of Oregon, Eugene
| | - Nicole Rogus-Pulia
- Division of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison
- Geriatric Research Education and Clinical Center, William S. Middleton Veterans' Hospital, Madison, WI
| |
Collapse
|
33
|
O'Neill M, Duffy O, Henderson M, Kernohan WG. Identification of eating, drinking and swallowing difficulties for people living with early-stage dementia: A systematic review. INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS 2023; 58:1994-2007. [PMID: 37483095 DOI: 10.1111/1460-6984.12924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Accepted: 06/19/2023] [Indexed: 07/25/2023]
Abstract
BACKGROUND The prevalence of dementia is increasing, bringing a range of challenges, such as eating, drinking and swallowing (EDS) difficulties, that are associated with aspiration, which can be fatal. Early identification of EDS difficulty in early-stage dementia could prevent complications, but reliable indicators are needed to help develop pathways to support the diagnosis. Previous reviews of this area require updating. AIMS To identify reliable and clinically measurable indicators of EDS difficulty used in early-stage dementia. METHODS & PROCEDURES A systematic search was conducted using common databases (MEDLINE, EMBASE and PsychInfo). Articles reporting indicators of EDS difficulty in early-stage dementia or mild cognitive impairment were included. The reliability of included studies was critically appraised using the risk of bias tools. Study outcomes were narratively reviewed by considering the reliability, clinical measurability and applicability of EDS indicators to early-stage dementia. OUTCOMES & RESULTS Initial searches returned 2443 articles. After removing duplicates, limiting to English language and human studies, 1589 articles remained. After reviewing titles, 60 abstracts were reviewed, yielding 18 full-text articles. A total of 12 articles were excluded that did not report at least one indicator of EDS difficulty in early-stage dementia, or where the reported association was not strong. Six included studies that reported eight indicators of EDS difficulty in early-stage dementia (four studies including people with Alzheimer's disease). On the balance of measurability, reliability and applicability, the most promising indicators of EDS difficulty were: delayed oral transit, rinsing ability, sarcopenia and polypharmacy. Additional, less reliable and applicable indicators included: always opened lips and non-amnestic mild cognitive impairment, especially in men. The delayed pharyngeal response is subjectively measured when instrumental assessment is not available and the 'candy sucking test' cannot be recommended because there is an inherent choking risk. CONCLUSIONS & IMPLICATIONS EDS difficulty in early-stage dementia can be highlighted by indicators that could be combined to create enhanced pathways to support the early identification of EDS difficulties for people living with early-stage dementia with a view to preventing complications and facilitating informed discussions regarding wishes in the event of further deterioration. Exploring the experiences of people living with dementia and their families' perspectives on potential indicators of EDS difficulty may add to the existing evidence base. WHAT THIS PAPER ADDS What is already known on the subject Early identification of EDS difficulty in early-stage dementia may prevent complications, but more reliable and clinically measurable indicators of EDS difficulty are needed to help develop pathways to support diagnosis. What this paper adds to existing knowledge A comprehensive range of studies related to EDS identification in early-stage dementia have been selected and reviewed. Across six included studies, the most promising indicators of EDS difficulty in early-stage dementia included delayed oral transit, poor rinsing ability, presence of sarcopenia and polypharmacy. What are the potential or actual clinical implications of this work? This study could help to develop pathways to support the early identification of EDS difficulties for people living with early-stage dementia with a view to preventing complications and facilitating informed discussions regarding wishes in the event of further deterioration.
Collapse
Affiliation(s)
- Michelle O'Neill
- Speech and Language Therapy, School of Health Sciences, Ulster University, Londonderry, UK
- Institute of Nursing and Health Research, Ulster University, Londonderry, UK
| | - Orla Duffy
- Speech and Language Therapy, School of Health Sciences, Ulster University, Londonderry, UK
- Institute of Nursing and Health Research, Ulster University, Londonderry, UK
| | - Mo Henderson
- Northern Health and Social Care Trust, Antrim, UK
| | - W George Kernohan
- Institute of Nursing and Health Research, Ulster University, Londonderry, UK
| |
Collapse
|
34
|
Al‐Alsheikh AS, Alabdulkader S, Miras AD, Goldstone AP. Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies. Obes Rev 2023; 24:e13620. [PMID: 37699864 PMCID: PMC10909448 DOI: 10.1111/obr.13620] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2022] [Revised: 04/05/2023] [Accepted: 07/10/2023] [Indexed: 09/14/2023]
Abstract
This systematic review collates studies of dietary or bariatric surgery interventions for obesity using positron emission tomography and single-photon emission computed tomography. Of 604 publications identified, 22 met inclusion criteria. Twelve studies assessed bariatric surgery (seven gastric bypass, five gastric bypass/sleeve gastrectomy), and ten dietary interventions (six low-calorie diet, three very low-calorie diet, one prolonged fasting). Thirteen studies examined neurotransmitter systems (six used tracers for dopamine DRD2/3 receptors: two each for 11 C-raclopride, 18 F-fallypride, 123 I-IBZM; one for dopamine transporter, 123 I-FP-CIT; one used tracer for serotonin 5-HT2A receptor, 18 F-altanserin; two used tracers for serotonin transporter, 11 C-DASB or 123 I-FP-CIT; two used tracer for μ-opioid receptor, 11 C-carfentanil; one used tracer for noradrenaline transporter, 11 C-MRB); seven studies assessed glucose uptake using 18 F-fluorodeoxyglucose; four studies assessed regional cerebral blood flow using 15 O-H2 O (one study also used arterial spin labeling); and two studies measured fatty acid uptake using 18 F-FTHA and one using 11 C-palmitate. The review summarizes findings and correlations with clinical outcomes, eating behavior, and mechanistic mediators. The small number of studies using each tracer and intervention, lack of dietary intervention control groups in any surgical studies, heterogeneity in time since intervention and degree of weight loss, and small sample sizes hindered the drawing of robust conclusions across studies.
Collapse
Affiliation(s)
- Alhanouf S. Al‐Alsheikh
- Department of Metabolism, Digestion and Reproduction, Imperial College LondonHammersmith HospitalLondonUK
- Department of Community Health Sciences, College of Applied Medical SciencesKing Saud UniversityRiyadhSaudi Arabia
| | - Shahd Alabdulkader
- Department of Metabolism, Digestion and Reproduction, Imperial College LondonHammersmith HospitalLondonUK
- Department of Health Sciences, College of Health and Rehabilitation SciencesPrincess Nourah Bint Abdulrahman UniversityRiyadhSaudi Arabia
| | - Alexander D. Miras
- Department of Metabolism, Digestion and Reproduction, Imperial College LondonHammersmith HospitalLondonUK
- School of Medicine, Faculty of Life and Health SciencesUlster UniversityLondonderryUK
| | - Anthony P. Goldstone
- PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Imperial College LondonHammersmith HospitalLondonUK
| |
Collapse
|
35
|
Nagahama T, Nakajima H, Wakuta M, Kasahara Y, Narita K, Nagahama S. Administration of amyloid-β oligomer to the buccal ganglia may reduce food intake and cholinergic synaptic responses within the feeding neural circuit in Aplysia kurodai. Neurosci Res 2023; 196:32-39. [PMID: 37328111 DOI: 10.1016/j.neures.2023.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Revised: 05/23/2023] [Accepted: 06/11/2023] [Indexed: 06/18/2023]
Abstract
Anorexia is a behavioral change caused by functional brain disorders in patients with Alzheimer's disease (AD). Amyloid-β (1-42) oligomers (o-Aβ) are possible causative agents of AD that impair signaling via synaptic dysfunction. In this study, we used Aplysia kurodai to study functional disorders of the brain through o-Aβ. Administration of o-Aβ to the buccal ganglia (feeding brain for oral movements) by surgical treatment significantly reduced food intake for at least five days. Furthermore, we explored the effects of o-Aβ on the synaptic function in the feeding neural circuit, focusing on a specific inhibitory synaptic response in jaw-closing motor neurons produced by cholinergic buccal multi-action neurons because we recently found that this cholinergic response decreases with aging, which is consistent with the cholinergic hypothesis for aging. Administration of o-Aβ to the buccal ganglia significantly reduced the synaptic response within minutes, whereas administration of amyloid-β (1-42) monomers did not. These results suggest that o-Aβ may impair the cholinergic synapses, even in Aplysia, which is consistent with the cholinergic hypothesis for AD.
Collapse
Affiliation(s)
- Tatsumi Nagahama
- Department of Biophysics, Faculty of Pharmaceutical Science, Toho University, Funabashi 274-8510, Japan; Faculty of Health and Medical Science, Teikyo Heisei University, Tokyo 170-8445, Japan.
| | - Hiroshi Nakajima
- Department of Biophysics, Faculty of Pharmaceutical Science, Toho University, Funabashi 274-8510, Japan
| | - Mizuki Wakuta
- Department of Biophysics, Faculty of Pharmaceutical Science, Toho University, Funabashi 274-8510, Japan
| | - Yuse Kasahara
- Department of Biophysics, Faculty of Pharmaceutical Science, Toho University, Funabashi 274-8510, Japan
| | - Kouki Narita
- Department of Biophysics, Faculty of Pharmaceutical Science, Toho University, Funabashi 274-8510, Japan
| | - Setsuko Nagahama
- Faculty of Health and Medical Science, Teikyo Heisei University, Tokyo 170-8445, Japan
| |
Collapse
|
36
|
Sun W, Matsuoka T, Imai A, Narumoto J. Relationship between eating problems and the risk of dementia: A retrospective study. Psychogeriatrics 2023; 23:1043-1050. [PMID: 37806970 DOI: 10.1111/psyg.13028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 08/24/2023] [Accepted: 09/14/2023] [Indexed: 10/10/2023]
Abstract
BACKGROUND Older adults and individuals with decreased cognition often experience appetite changes and weight loss. As weight loss can result in cognitive decline, change in appetite may be an important contributor to the onset of dementia. However, there is a lack of relevant studies on this topic. This study aimed to determine the relationship between appetite changes, weight loss, and dementia onset. METHODS A total of 135 patients with normal cognitive function, subjective cognitive impairment, and mild cognitive impairment who were assessed using the Neuropsychiatric Inventory 12 item version (NPI-12) and followed up for at least 1 month were enrolled in the study. All patients underwent a Mini-Mental State Examination (MMSE). Eating problems were assessed using the NPI Eating Problems Score. Appetite and weight loss were assessed at the first visit by caregivers. Kaplan-Meier survival analyses with a log-rank test were used to compare the time to the onset of dementia between the presence or absence of the NPI eating problems, appetite loss, weight loss, or NPI depression scores. Cox proportional hazards regression models using the forced entry method were employed to estimate the hazard ratio (HR) for dementia. RESULTS Weight loss was significantly related to dementia onset (P = 0.027) in the Kaplan-Meier survival analyses, while eating problems, appetite loss, and depression showed no significant association (P = 0.519, P = 0.326, and P = 0.317, respectively). In the Cox proportional hazards regression models, the MMSE score was found to be a significant factor (P = 0.021, HR = 0.871); moreover, weight loss tended to increase the risk of dementia onset (P = 0.057, HR = 1.694). CONCLUSIONS Weight loss experienced by older adults could contribute to an increased risk of developing dementia.
Collapse
Affiliation(s)
- Weiyi Sun
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Teruyuki Matsuoka
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
- Department of Psychiatry, National Hospital Organization Maizuru Medical Center, Kyoto, Japan
| | - Ayu Imai
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Jin Narumoto
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| |
Collapse
|
37
|
Bogdan S, Puścion-Jakubik A, Klimiuk K, Socha K, Kochanowicz J, Gorodkiewicz E. The Levels of Leptin, Cystatin C, Neuropilin-1 and Tau Protein in Relation to Dietary Habits in Patients with Alzheimer's Disease. J Clin Med 2023; 12:6855. [PMID: 37959320 PMCID: PMC10650913 DOI: 10.3390/jcm12216855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 10/22/2023] [Accepted: 10/26/2023] [Indexed: 11/15/2023] Open
Abstract
Alzheimer's disease (AD) is the most common form of dementia in older people. Its prevalence is expected to increase, and therefore it poses a serious challenge to the healthcare system. The aim of the study was to assess the concentration of leptin, cystatin C, neuropilin-1 and tau protein, as well as the influence of dietary habits on these parameters, in a group of AD patients (n = 110) compared to 60 healthy people (n = 60). It has been shown that AD patients, compared to healthy people, are characterized by significantly higher median concentrations of leptin (9.97 vs. 3.08), cystatin c (1.53 vs. 0.56) and tau protein (8.46 vs. 4.19), but significantly lower median neuropilin-1 (69.94 vs. 167.28). Multiple regression analyses showed that leptin levels could be explained by dietary habits in 27%, cystatin C in 51%, neuropilin-1 in 41% and tau protein in 25% of cases. Modification of eating habits may contribute to improving the values of the discussed parameters.
Collapse
Affiliation(s)
- Sylwia Bogdan
- Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciołkowskiego 1K, 15-245 Bialystok, Poland; (S.B.); (E.G.)
| | - Anna Puścion-Jakubik
- Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Mickiewicza 2D Street, 15-222 Bialystok, Poland;
| | - Katarzyna Klimiuk
- Podlasie Center of Psychogeriatrics, Swobodna 38 Street, 15-756 Bialystok, Poland;
| | - Katarzyna Socha
- Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Mickiewicza 2D Street, 15-222 Bialystok, Poland;
| | - Jan Kochanowicz
- Department of Neurology, Medical University of Białystok, M. Skłodowskiej-Curie 24a Street, 15-276 Bialystok, Poland;
| | - Ewa Gorodkiewicz
- Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciołkowskiego 1K, 15-245 Bialystok, Poland; (S.B.); (E.G.)
| |
Collapse
|
38
|
Mehramiz M, Porter T, O’Brien EK, Rainey-Smith SR, Laws SM. A Potential Role for Sirtuin-1 in Alzheimer's Disease: Reviewing the Biological and Environmental Evidence. J Alzheimers Dis Rep 2023; 7:823-843. [PMID: 37662612 PMCID: PMC10473168 DOI: 10.3233/adr-220088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 07/08/2023] [Indexed: 09/05/2023] Open
Abstract
Sirtuin-1 (Sirt1), encoded by the SIRT1 gene, is a conserved Nicotinamide adenine dinucleotide (NAD+) dependent deacetylase enzyme, considered as the master regulator of metabolism in humans. Sirt1 contributes to a wide range of biological pathways via several mechanisms influenced by lifestyle, such as diet and exercise. The importance of a healthy lifestyle is of relevance to highly prevalent modern chronic diseases, such as Alzheimer's disease (AD). There is growing evidence at multiple levels for a role of Sirt1/SIRT1 in AD pathological mechanisms. As such, this review will explore the relevance of Sirt1 to AD pathological mechanisms, by describing the involvement of Sirt1/SIRT1 in the development of AD pathological hallmarks, through its impact on the metabolism of amyloid-β and degradation of phosphorylated tau. We then explore the involvement of Sirt1/SIRT1 across different AD-relevant biological processes, including cholesterol metabolism, inflammation, circadian rhythm, and gut microbiome, before discussing the interplay between Sirt1 and AD-related lifestyle factors, such as diet, physical activity, and smoking, as well as depression, a common comorbidity. Genome-wide association studies have explored potential associations between SIRT1 and AD, as well as AD risk factors and co-morbidities. We summarize this evidence at the genetic level to highlight links between SIRT1 and AD, particularly associations with AD-related risk factors, such as heart disease. Finally, we review the current literature of potential interactions between SIRT1 genetic variants and lifestyle factors and how this evidence supports the need for further research to determine the relevance of these interactions with respect to AD and dementia.
Collapse
Affiliation(s)
- Mehrane Mehramiz
- Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia
- Collaborative Genomics and Translation Group, Edith Cowan University, Joondalup, Western Australia, Australia
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
| | - Tenielle Porter
- Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia
- Collaborative Genomics and Translation Group, Edith Cowan University, Joondalup, Western Australia, Australia
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
- Curtin Medical School, Curtin University, Bentley, Western Australia, Australia
| | - Eleanor K. O’Brien
- Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia
- Collaborative Genomics and Translation Group, Edith Cowan University, Joondalup, Western Australia, Australia
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
| | - Stephanie R. Rainey-Smith
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
- Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia
- School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia
| | - Simon M. Laws
- Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia
- Collaborative Genomics and Translation Group, Edith Cowan University, Joondalup, Western Australia, Australia
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
- Curtin Medical School, Curtin University, Bentley, Western Australia, Australia
| |
Collapse
|
39
|
Morrow CB, Leoutsakos J, Yan H, Onyike C, Kamath V. Weight Change and Neuropsychiatric Symptoms in Alzheimer's Disease and Frontotemporal Dementia: Associations with Cognitive Decline. J Alzheimers Dis Rep 2023; 7:767-774. [PMID: 37662607 PMCID: PMC10473120 DOI: 10.3233/adr-230034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Accepted: 06/29/2023] [Indexed: 09/05/2023] Open
Abstract
Weight changes, neuropsychiatric symptoms (NPS), and cognitive decline often coincide in Alzheimer's disease (AD) and frontotemporal dementia (FTD); however, the direction of their relationship remains unclear. This study aims to clarify the connection between weight changes, NPS, and cognition in AD and FTD. We found that cognitive decline was associated with decreased body mass index (BMI) in AD, while BMI gain was associated with increased conversion to FTD. Elevated NPS were associated with decreased BMI in AD and increased BMI in FTD. Identifying early changes in NPS and BMI may facilitate the detection of cognitive decline, providing an opportunity for early intervention.
Collapse
Affiliation(s)
- Christopher B. Morrow
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Jeannie Leoutsakos
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Haijuan Yan
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Chiadi Onyike
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| | - Vidyulata Kamath
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
| |
Collapse
|
40
|
Moreira VS, Chaves MLF, de Castilhos RM, Olchik MR. Caregiver burden related to feeding process in Alzheimer's disease. Dement Neuropsychol 2023; 17:e20220092. [PMID: 37533596 PMCID: PMC10392878 DOI: 10.1590/1980-5764-dn-2022-0092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 03/16/2023] [Accepted: 04/16/2023] [Indexed: 08/04/2023] Open
Abstract
Difficulties in the feeding process, such as aversive feeding behaviors and dysphagia, are common in patients with Alzheimer's disease (AD) and can often overload their caregivers. Although dysphagia is already established as a factor contributing to caregiver burden, the impact of aversive behaviors is less studied. Objectives Evaluate the relationship between the feeding process in individuals with AD and their caregiver's burden. Methods Dyads of individuals with AD and their caregivers were recruited for a cross-sectional study. The Edinburgh Feeding Evaluation in Dementia (EdFED) scale, the Zarit Burden Interview (ZBI), the mini-mental state examination (MMSE), the Functional Activities Questionnaire (FAQ), and the Functional Oral Intake scale (FOIS) were performed. Results We included 60 AD individuals-caregivers dyads. The median (IQR) age of caregivers was 57 (19-81) years, and the most were females (70%). The individuals with AD had a median MMSE of 12 (6-15), and the disease duration was 4 (2-6) years. The mean (SD) Zarit score was 20.95 (6.51). In the multivariate linear regression, the EdFED score (95% CI 0.368-1.465) and time as a caregiver (95% CI 0.133-1.355) were associated with the caregiver's burden. Conclusions Aversive behaviors were associated with the caregiver burden of individuals with AD, even with a short duration of the disease. These findings show the importance of education for caregivers regarding the feeding process, as these measures have great potential to minimize the caregiver's burden.
Collapse
Affiliation(s)
- Verônica Salazar Moreira
- Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Medicina, Ciências Médicas, Porto Alegre RS, Brazil
| | - Márcia Lorena Fagundes Chaves
- Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Medicina, Ciências Médicas, Porto Alegre RS, Brazil
- Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Departamento de Medicina Interna, Porto Alegre RS, Brazil
| | - Raphael Machado de Castilhos
- Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Medicina, Ciências Médicas, Porto Alegre RS, Brazil
- Hospital de Clínicas de Porto Alegre, Serviço de Neurologia, Porto Alegre RS, Brazil
| | - Maira Rozenfeld Olchik
- Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Medicina, Ciências Médicas, Porto Alegre RS, Brazil
- Hospital de Clínicas de Porto Alegre, Serviço de Neurologia, Porto Alegre RS, Brazil
- Universidade Federal do Rio Grande do Sul, Faculdade de Odontologia, Curso de Fonoaudiologia, Departamento de Cirurgia e Ortopedia, Porto Alegre RS, Brazil
| |
Collapse
|
41
|
Schimmel M, Anliker N, Sabatini GP, De Paula MS, Weber AR, Molinero-Mourelle P. Assessment and Improvement of Masticatory Performance in Frail Older People: A Narrative Review. J Clin Med 2023; 12:jcm12113760. [PMID: 37297955 DOI: 10.3390/jcm12113760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/23/2023] [Accepted: 05/24/2023] [Indexed: 06/12/2023] Open
Abstract
According to the World Health Organization (WHO), the estimated number of older adults is around 962 million and is projected to increase to 2.1 billion by 2050. The oral frailty concept is associated with gradual oral function loss in relation to aging. There is a need to emphasize the improvement of oral function based on an evaluation of masticatory performance in patients with various oral conditions or systemic diseases and especially in the frail elderly. The present narrative review presents an overview of the current state of the assessment and improvement of masticatory performance in frail older people. To fully encompass oral frailty, oro-facial hypofunction, or oro-facial fitness, dental Patient Reported Outcomes (dPROs) should be included; nevertheless, there are limited evidence-based rehabilitation approaches. The concept of oral frailty, oro-facial hypofunction, or oro-facial fitness should involve dental Patient Reported Outcomes (dPROs), and in this sense, there are only a few evidence-based rehabilitation procedures to improve oro-facial hypofunction besides prosthodontics. It must be considered that reduced neuroplastic capacity in old individuals might preclude a positive outcome of these strategies that might need to be accompanied by functional training and nutritional counseling.
Collapse
Affiliation(s)
- Martin Schimmel
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
- Division of Gerodontology and Removable Prosthodontics, University Clinics of Dental Medicine, University of Geneva, 1211 Geneva, Switzerland
| | - Noemi Anliker
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
| | - Gabriela Panca Sabatini
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
- Department of Prosthodontics, University of São Paulo (USP), São Paulo 05508-900, Brazil
| | - Marcella Silva De Paula
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
- Department of Prevention and Oral Rehabilitation, Universidade Federal de Goiás, Goiania 74690-900, Brazil
| | - Adrian Roman Weber
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
| | - Pedro Molinero-Mourelle
- Department of Reconstructive Dentistry and Gerodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland
| |
Collapse
|
42
|
Hardy CJD, Taylor-Rubin C, Taylor B, Harding E, Gonzalez AS, Jiang J, Thompson L, Kingma R, Chokesuwattanaskul A, Walker F, Barker S, Brotherhood E, Waddington C, Wood O, Zimmermann N, Kupeli N, Yong KXX, Camic PM, Stott J, Marshall CR, Oxtoby NP, Rohrer JD, Volkmer A, Crutch SJ, Warren JD. Symptom-led staging for primary progressive aphasia. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.03.13.23286972. [PMID: 36993460 PMCID: PMC10055437 DOI: 10.1101/2023.03.13.23286972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/19/2023]
Abstract
The primary progressive aphasias (PPA) present complex and diverse challenges of diagnosis, management and prognosis. A clinically-informed, syndromic staging system for PPA would take a substantial step toward meeting these challenges. This study addressed this need using detailed, multi-domain mixed-methods symptom surveys of people with lived experience in a large international PPA cohort. We administered structured online surveys to caregivers of patients with a canonical PPA syndromic variant (nonfluent/agrammatic (nvPPA), semantic (svPPA) or logopenic (lvPPA)). In an 'exploratory' survey, a putative list and ordering of verbal communication and nonverbal functioning (nonverbal thinking, conduct and wellbeing, physical) symptoms was administered to 118 caregiver members of the UK national PPA Support Group. Based on feedback, we expanded the symptom list and created six provisional clinical stages for each PPA subtype. In a 'consolidation' survey, these stages were presented to 110 caregiver members of UK and Australian PPA Support Groups, and refined based on quantitative and qualitative feedback. Symptoms were retained if rated as 'present' by a majority (at least 50%) of respondents representing that PPA syndrome, and assigned to a consolidated stage based on majority consensus; the confidence of assignment was estimated for each symptom as the proportion of respondents in agreement with the final staging for that symptom. Qualitative responses were analysed using framework analysis. For each PPA syndrome, six stages ranging from 1 ('Very mild') to 6 ('Profound') were identified; earliest stages were distinguished by syndromic hallmark symptoms of communication dysfunction, with increasing trans-syndromic convergence and dependency for basic activities of daily living at later stages. Spelling errors, hearing changes and nonverbal behavioural features were reported at early stages in all syndromes. As the illness evolved, swallowing and mobility problems were reported earlier in nfvPPA than other syndromes, while difficulty recognising familiar people and household items characterised svPPA and visuospatial symptoms were more prominent in lvPPA. Overall confidence of symptom staging was higher for svPPA than other syndromes. Across syndromes, functional milestones were identified as key deficits that predict the sequence of major daily life impacts and associated management needs. Qualitatively, we identified five major themes encompassing 15 subthemes capturing respondents' experiences of PPA and suggestions for staging implementation. This work introduces a prototypical, symptom-led staging scheme for canonical PPA syndromes: the PPA Progression Planning Aid (PPA 2 ). Our findings have implications for diagnostic and care pathway guidelines, trial design and personalised prognosis and treatment for people living with these diseases.
Collapse
Affiliation(s)
- Chris JD Hardy
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Cathleen Taylor-Rubin
- Uniting War Memorial Hospital, Sydney, Australia
- Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
| | - Beatrice Taylor
- Centre for Medical Image Computing, Department of Computer Science, UCL, London, UK
| | - Emma Harding
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Aida Suarez Gonzalez
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Jessica Jiang
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | | | | | - Anthipa Chokesuwattanaskul
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
- Division of Neurology, Department of Internal Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
- Cognitive Clinical and Computational Neuroscience Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
| | | | - Suzie Barker
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Emilie Brotherhood
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Claire Waddington
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Olivia Wood
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Nikki Zimmermann
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Nuriye Kupeli
- Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL, London, UK
| | - Keir XX Yong
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Paul M Camic
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Josh Stott
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
- ADAPTlab, Research Department of Clinical, Educational and Health Psychology, UCL, London, UK
| | | | - Neil P. Oxtoby
- Centre for Medical Image Computing, Department of Computer Science, UCL, London, UK
| | - Jonathan D Rohrer
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Anna Volkmer
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
- Psychology and Language Sciences (PALS), UCL, London, UK
| | - Sebastian J Crutch
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| | - Jason D Warren
- Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK
| |
Collapse
|
43
|
Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders. J Neurol 2023; 270:2674-2687. [PMID: 36811680 PMCID: PMC10129920 DOI: 10.1007/s00415-023-11596-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 01/26/2023] [Accepted: 01/28/2023] [Indexed: 02/24/2023]
Abstract
Most neuropsychiatric symptoms (NPS) common in frontotemporal dementia (FTD) are currently not part of the Neuropsychiatric Inventory (NPI). We piloted an FTD Module that included eight extra items to be used in conjunction with the NPI. Caregivers of patients with behavioural variant FTD (n = 49), primary progressive aphasia (PPA; n = 52), Alzheimer's dementia (AD; n = 41), psychiatric disorders (n = 18), presymptomatic mutation carriers (n = 58) and controls (n = 58) completed the NPI and FTD Module. We investigated (concurrent and construct) validity, factor structure and internal consistency of the NPI and FTD Module. We performed group comparisons on item prevalence, mean item and total NPI and NPI with FTD Module scores, and multinomial logistic regression to determine its classification abilities. We extracted four components, together explaining 64.1% of the total variance, of which the largest indicated the underlying dimension 'frontal-behavioural symptoms'. Whilst apathy (original NPI) occurred most frequently in AD, logopenic and non-fluent variant PPA, the most common NPS in behavioural variant FTD and semantic variant PPA were loss of sympathy/empathy and poor response to social/emotional cues (part of FTD Module). Patients with primary psychiatric disorders and behavioural variant FTD showed the most severe behavioural problems on both the NPI as well as the NPI with FTD Module. The NPI with FTD Module correctly classified more FTD patients than the NPI alone. By quantifying common NPS in FTD the NPI with FTD Module has large diagnostic potential. Future studies should investigate whether it can also prove a useful addition to the NPI in therapeutic trials.
Collapse
|
44
|
Chokesuwattanaskul A, Jiang H, Bond RL, Jimenez DA, Russell LL, Sivasathiaseelan H, Johnson JCS, Benhamou E, Agustus JL, van Leeuwen JEP, Chokesuwattanaskul P, Hardy CJD, Marshall CR, Rohrer JD, Warren JD. The architecture of abnormal reward behaviour in dementia: multimodal hedonic phenotypes and brain substrate. Brain Commun 2023; 5:fcad027. [PMID: 36942157 PMCID: PMC10023829 DOI: 10.1093/braincomms/fcad027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 10/11/2022] [Accepted: 02/07/2023] [Indexed: 02/11/2023] Open
Abstract
Abnormal reward processing is a hallmark of neurodegenerative diseases, most strikingly in frontotemporal dementia. However, the phenotypic repertoire and neuroanatomical substrates of abnormal reward behaviour in these diseases remain incompletely characterized and poorly understood. Here we addressed these issues in a large, intensively phenotyped patient cohort representing all major syndromes of sporadic frontotemporal dementia and Alzheimer's disease. We studied 27 patients with behavioural variant frontotemporal dementia, 58 with primary progressive aphasia (22 semantic variant, 24 non-fluent/agrammatic variant and 12 logopenic) and 34 with typical amnestic Alzheimer's disease, in relation to 42 healthy older individuals. Changes in behavioural responsiveness were assessed for canonical primary rewards (appetite, sweet tooth, sexual activity) and non-primary rewards (music, religion, art, colours), using a semi-structured survey completed by patients' primary caregivers. Changes in more general socio-emotional behaviours were also recorded. We applied multiple correspondence analysis and k-means clustering to map relationships between hedonic domains and extract core factors defining aberrant hedonic phenotypes. Neuroanatomical associations were assessed using voxel-based morphometry of brain MRI images across the combined patient cohort. Altered (increased and/or decreased) reward responsiveness was exhibited by most patients in the behavioural and semantic variants of frontotemporal dementia and around two-thirds of patients in other dementia groups, significantly (P < 0.05) more frequently than in healthy controls. While food-directed changes were most prevalent across the patient cohort, behavioural changes directed toward non-primary rewards occurred significantly more frequently (P < 0.05) in the behavioural and semantic variants of frontotemporal dementia than in other patient groups. Hedonic behavioural changes across the patient cohort were underpinned by two principal factors: a 'gating' factor determining the emergence of altered reward behaviour and a 'modulatory' factor determining how that behaviour is directed. These factors were expressed jointly in a set of four core, trans-diagnostic and multimodal hedonic phenotypes: 'reward-seeking', 'reward-restricted', 'eating-predominant' and 'control-like'-variably represented across the cohort and associated with more pervasive socio-emotional behavioural abnormalities. The principal gating factor was associated (P < 0.05 after correction for multiple voxel-wise comparisons over the whole brain) with a common profile of grey matter atrophy in anterior cingulate, bilateral temporal poles, right middle frontal and fusiform gyri: the cortical circuitry that mediates behavioural salience and semantic and affective appraisal of sensory stimuli. Our findings define a multi-domain phenotypic architecture for aberrant reward behaviours in major dementias, with novel implications for the neurobiological understanding and clinical management of these diseases.
Collapse
Affiliation(s)
- Anthipa Chokesuwattanaskul
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
- Division of Neurology, Department of Internal Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
- Cognitive Clinical and Computational Neuroscience Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
| | - Harmony Jiang
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Rebecca L Bond
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Daniel A Jimenez
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
- Department of Neurological Sciences, Faculty of Medicine, University of Chile, Santiago, Chile
| | - Lucy L Russell
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Harri Sivasathiaseelan
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Jeremy C S Johnson
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Elia Benhamou
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Jennifer L Agustus
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Janneke E P van Leeuwen
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | | | - Chris J D Hardy
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Charles R Marshall
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
- Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
| | - Jonathan D Rohrer
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Jason D Warren
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK
| |
Collapse
|
45
|
Makdissi S, Parsons BD, Di Cara F. Towards early detection of neurodegenerative diseases: A gut feeling. Front Cell Dev Biol 2023; 11:1087091. [PMID: 36824371 PMCID: PMC9941184 DOI: 10.3389/fcell.2023.1087091] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 01/20/2023] [Indexed: 02/10/2023] Open
Abstract
The gastrointestinal tract communicates with the nervous system through a bidirectional network of signaling pathways called the gut-brain axis, which consists of multiple connections, including the enteric nervous system, the vagus nerve, the immune system, endocrine signals, the microbiota, and its metabolites. Alteration of communications in the gut-brain axis is emerging as an overlooked cause of neuroinflammation. Neuroinflammation is a common feature of the pathogenic mechanisms involved in various neurodegenerative diseases (NDs) that are incurable and debilitating conditions resulting in progressive degeneration and death of neurons, such as in Alzheimer and Parkinson diseases. NDs are a leading cause of global death and disability, and the incidences are expected to increase in the following decades if prevention strategies and successful treatment remain elusive. To date, the etiology of NDs is unclear due to the complexity of the mechanisms of diseases involving genetic and environmental factors, including diet and microbiota. Emerging evidence suggests that changes in diet, alteration of the microbiota, and deregulation of metabolism in the intestinal epithelium influence the inflammatory status of the neurons linked to disease insurgence and progression. This review will describe the leading players of the so-called diet-microbiota-gut-brain (DMGB) axis in the context of NDs. We will report recent findings from studies in model organisms such as rodents and fruit flies that support the role of diets, commensals, and intestinal epithelial functions as an overlooked primary regulator of brain health. We will finish discussing the pivotal role of metabolisms of cellular organelles such as mitochondria and peroxisomes in maintaining the DMGB axis and how alteration of the latter can be used as early disease makers and novel therapeutic targets.
Collapse
Affiliation(s)
- Stephanie Makdissi
- Dalhousie University, Department of Microbiology and Immunology, Halifax, NS, Canada
- IWK Health Centre, Department of Pediatrics, Halifax, Canada
| | - Brendon D. Parsons
- Dalhousie University, Department of Microbiology and Immunology, Halifax, NS, Canada
| | - Francesca Di Cara
- Dalhousie University, Department of Microbiology and Immunology, Halifax, NS, Canada
- IWK Health Centre, Department of Pediatrics, Halifax, Canada
| |
Collapse
|
46
|
Okahara K, Ohsawa M, Haruta-Tsukamoto A, Miyoshi R, Funahashi H, Fukutani Y, Makita S, Matsuo H, Ishida Y. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO). J Alzheimers Dis Rep 2023; 7:107-117. [PMID: 36891253 PMCID: PMC9986705 DOI: 10.3233/adr-220074] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Accepted: 01/02/2023] [Indexed: 01/25/2023] Open
Abstract
Background Alzheimer's disease (AD) and dementia have increasingly been conceived of as "complex diseases of aging", determined by multiple, simultaneous, interacting pathophysiological processes. The condition known as frailty is a phenotype of aging and its comprehensive pathophysiology is thought to be closely related to the incidence of mild cognitive impairment (MCI) and the exacerbation of dementia. Objective This study aimed to investigate the effect of the multicomponent drug, ninjin'yoeito (NYT), on frailty in MCI and mild AD patients. Methods This study was an open-label trial. A total of 14 patients, including 9 with MCI and 5 with mild AD, were enrolled. Among them, 11 were frail while 3 were prefrail. NYT (6-9 g/day) was administered orally for 24 weeks, and assessments were carried out at baseline (week 0), and at 4, 8, 16, and 24 weeks. Results In the primary endpoint, significant early improvements were observed in the anorexia scores according to the Neuropsychiatric Inventory after four weeks of treatment with NYT. The Cardiovascular Health Study score was significantly improved, and no frailty was observed after 24 weeks. The fatigue visual analog scale scores also significantly improved. The Clinical Dementia Rating and the Montreal Cognitive Assessment scores remained at baseline levels during the NYT treatment period. Conclusion The results suggest that NYT may be effective in the treatment of frailty, especially for anorexia and fatigue, in both MCI and mild AD patients, which would be beneficial for the prognosis of dementia.
Collapse
Affiliation(s)
| | | | - Ayaka Haruta-Tsukamoto
- Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan
| | - Ryoei Miyoshi
- Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan.,Heartopia Miyoshi Clinic, Miyazaki-city, Miyazaki, Japan
| | - Hideki Funahashi
- Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan
| | | | | | - Hisae Matsuo
- Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan.,Center for Health Sciences and Counseling, Kyushu University, Nishi-ku, Fukuoka, Japan
| | - Yasushi Ishida
- Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki-city, Miyazaki, Japan
| |
Collapse
|
47
|
Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease. Phys Life Rev 2022; 43:32-95. [PMID: 36179555 DOI: 10.1016/j.plrev.2022.07.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 07/28/2022] [Indexed: 12/15/2022]
Abstract
The past three decades have seen multiple reports of people with neurodegenerative disorders, or other forms of changes in their brains, who also show putative changes in how they approach and produce visual art. Authors argue that these cases may provide a unique body of evidence, so-called 'artistic signatures' of neurodegenerative diseases, that might be used to understand disorders, provide diagnoses, be employed in treatment, create patterns of testable hypotheses for causative study, and also provide unique insight into the neurobiological linkages between the mind, brain, body, and the human penchant for art-making itself. However-before we can begin to meaningfully build from such emerging findings, much less formulate applications-not only is such evidence currently quite disparate and in need of systematic review, almost all case reports and artwork ratings are entirely subjective, based on authors' personal observations or a sparse collection of methods that may not best fit underlying research aims. This leads to the very real question of whether we might actually find patterns of systematic change if fit to a rigorous review-Can we really 'read' art to illuminate possible changes in the brain? How might we best approach this topic in future neuroscientific, clinical, and art-related research? This paper presents a review of this field and answer to these questions. We consider the current case reports for seven main disorders-Alzheimer's and Parkinson's disease, frontotemporal and Lewy body dementia, corticobasal degeneration, aphasia, as well as stroke-consolidating arguments for factors and changes related to art-making and critiquing past methods. Taking the published artworks from these papers, we then conduct our own assessment, employing computerized and human-rater-based approaches, which we argue represent best practice to identify stylistic or creativity/quality changes. We suggest, indeed, some evidence for systematic patterns in art-making for specific disorders and also find that case authors showed rather high agreement with our own assessments. More important, through opening this topic and past evidence to a systematic review, we hope to open a discussion and provide a theoretical and empirical foundation for future application and research on the intersection of art-making and the neurotypical, the changed, and the artistic brain.
Collapse
|
48
|
Saito Y, Oguri T, Sakurai K, Kato H, Yuasa H. [Transient changes in food preference in a patient with cerebellar infarction]. Rinsho Shinkeigaku 2022; 62:781-786. [PMID: 36184412 DOI: 10.5692/clinicalneurol.cn-001755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
A 44-year-old woman was admitted to our hospital due to dizziness and ataxia of the trunk and right upper limb. Brain MRI revealed an acute infarct lesion in the right posterior inferior cerebellar artery territory. In addition to the cognitive deterioration observed in the subacute phase, a change was noted in her food preference-from light-tasting, low-caloric Japanese cuisine, sugarless coffee, and hot drinks to strong-tasting, high-caloric Western cuisine, sugar-rich coffee, and iced drinks. Single-photon emission computed tomography showed hypoperfusion in the bilateral frontal lobes and right cerebellum. These cognitive and food preference-related changes were gradually restored over six months after the onset. The reduced cerebral blood flow in the bilateral frontal lobes also restored along with the clinical improvement, with the maximal changes in the bilateral subcallosal areas. This case suggests that changes in food preference can occur as a symptom of cerebellar infarction, possibly by the mechanism similar to cerebellar cognitive affective syndrome.
Collapse
Affiliation(s)
| | | | - Keita Sakurai
- Department of Radiology, National Center for Geriatrics and Gerontology
| | - Hideki Kato
- Department of Neurology, Tosei General Hospital
| | | |
Collapse
|
49
|
Wu CY, Dodge HH, Gothard S, Mattek N, Wright K, Barnes LL, Silbert LC, Lim MM, Kaye JA, Beattie Z. Unobtrusive Sensing Technology Detects Ecologically Valid Spatiotemporal Patterns of Daily Routines Distinctive to Persons With Mild Cognitive Impairment. J Gerontol A Biol Sci Med Sci 2022; 77:2077-2084. [PMID: 34608939 PMCID: PMC9536445 DOI: 10.1093/gerona/glab293] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The ability to capture people's movement throughout their home is a powerful approach to inform spatiotemporal patterns of routines associated with cognitive impairment. The study estimated indoor room activities over 24 hours and investigated relationships between diurnal activity patterns and mild cognitive impairment (MCI). METHODS One hundred and sixty-one older adults (26 with MCI) living alone (age = 78.9 ± 9.2) were included from 2 study cohorts-the Oregon Center for Aging & Technology and the Minority Aging Research Study. Indoor room activities were measured by the number of trips made to rooms (bathroom, bedroom, kitchen, living room). Trips made to rooms (transitions) were detected using passive infrared motion sensors fixed on the walls for a month. Latent trajectory models were used to identify distinct diurnal patterns of room activities and characteristics associated with each trajectory. RESULTS Latent trajectory models identified 2 diurnal patterns of bathroom usage (high and low usage). Participants with MCI were more likely to be in the high bathroom usage group that exhibited more trips to the bathroom than the low-usage group (odds ratio [OR] = 4.1, 95% CI [1.3-13.5], p = .02). For kitchen activity, 2 diurnal patterns were identified (high and low activity). Participants with MCI were more likely to be in the high kitchen activity group that exhibited more transitions to the kitchen throughout the day and night than the low kitchen activity group (OR = 3.2, 95% CI [1.1-9.1], p = .03). CONCLUSIONS The linkage between bathroom and kitchen activities with MCI may be the result of biological, health, and environmental factors in play. In-home, real-time unobtrusive-sensing offers a novel way of delineating cognitive health with chronologically-ordered movement across indoor locations.
Collapse
Affiliation(s)
- Chao-Yi Wu
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Hiroko H Dodge
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Sarah Gothard
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Nora Mattek
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Kirsten Wright
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Lisa L Barnes
- Department of Neurological Sciences, Rush Medical College, Chicago, Illinois, USA
- Rush Alzheimer’s Disease Center, Rush Medical College, Chicago, Illinois, USA
| | - Lisa C Silbert
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
- Department of Neurology, Veterans Affairs Portland Health Care System, Portland, Oregon, USA
| | - Miranda M Lim
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Department of Neurology, Veterans Affairs Portland Health Care System, Portland, Oregon, USA
| | - Jeffrey A Kaye
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| | - Zachary Beattie
- Department of Neurology, Oregon Health & Science University (OHSU), School of Medicine, Portland, Oregon, USA
- Oregon Center for Aging & Technology (ORCATECH), OHSU, Portland, Oregon, USA
| |
Collapse
|
50
|
Otsuka R. Diet, nutrition, and cognitive function: A narrative review of Japanese longitudinal studies. Geriatr Gerontol Int 2022; 22:825-831. [PMID: 36002912 PMCID: PMC9805113 DOI: 10.1111/ggi.14463] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 04/19/2022] [Accepted: 07/20/2022] [Indexed: 01/09/2023]
Abstract
In aging societies, the number of older people with cognitive decline and dementia is increasing. Proper nutrition is a key factor that can help in the prevention of these age-related impairments. This narrative review of longitudinal studies in Japan outlines the relationship between nutrition and the brain and focuses on Japanese nutritional epidemiologic studies. The results of Japanese cohort studies suggest that rather than a single food or nutrient, a nutritionally balanced diet that integrates a variety of foods and nutrients can contribute to the maintenance of brain function and be effective in preventing dementia. In addition, this review considers a nutritional approach to reducing the severity of cognitive decline in individuals with mild cognitive impairment and dementia, and suggests lifelong strategies for the prevention of cognitive decline. It is important that we consider the practice of eating not only as a way to obtain nutrients, but also as an important lifestyle habit to maintain our physical and mental health. Geriatr Gerontol Int 2022; 22: 825-831.
Collapse
Affiliation(s)
- Rei Otsuka
- Department of Epidemiology of Aging, Center for Gerontology and Social Science, Research InstituteNational Center for Geriatrics and GerontologyAichiJapan
| |
Collapse
|